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Abstract 
 
Assessment of Protein Quality, Lipid Metabolism, Hepatic Transcriptome and Safety of a Silver 
Carp (Hypophthalmichthys molitrix) Derived Sarcoplasmic Protein Powder. 
 
Derek C. Warren  
 
Fishery resources are currently operating either near optimal yield or at levels with elevated risk for fish 
stock depletion. A solution for overcoming limitations of natural fish resources is through utilization of 
less desirable fish species and fish processing by-products. Water-soluble sarcoplasm proteins consist of 
25 – 30% of protein in carp, are lost in wash water during processing and can be recovered and freeze-
dried to produce a protein-rich powder (CSP). However, protein quality and safety of CSP must be 
evaluated prior to commercial use. High quality proteins are sought after in order to lower the amount of 
protein consumed for protein synthesis. Not only does this contribute to sustainability, but whey-based 
infant formulas with high protein content have been reported to increase body weight gain and risk of 
obesity at adulthood. However, low protein intake can risk protein-energy malnutrition characterized by 
fatty liver and hepatic dysfunction due to altered lipid metabolism.  
 
The objective of this project was: 1) to evaluate the protein quality of CSP and effects of low (10% kcal) 
protein diets on growth, body composition, renal and bone health, 2) to assess low protein (10 % kcal) 
diets consisting of CSP or commercial milk proteins effects on lipid metabolism in liver and adipose 
tissue compared to a protein deficient diet, and 3) to investigate distinct phenotypic and hepatic 
transcriptome responses to low protein (10% kcal) diets consisting of CSP, casein, and whey protein 
using a growing animal model. Young (age 28 days) female Sprague-Dawley rats were randomly 
assigned (n=8 rats/group) to standard purified diets consisting of 10% protein as CSP, casein, whey 
protein or a protein-free diet.  
 
Results showed greater (p < 0.05) fecal amino acid excretion in casein-fed rats, but no significant 
differences in liver and muscle amino acid profiles among protein diets. All low protein diets supported 
growth within the normal range, but whey protein-fed rats had greater (p < 0.05) adiposity. CSP, whey 
and casein-fed rats showed no differences in serum renal biomarkers or bone indices. In the liver, rats fed 
protein-free diet had the highest (p < 0.05) total hepatic lipid content and highest histological evidence of 
hepatocyte fat infiltration. Rats consuming CSP showed no differences in hepatic weight, fat infiltration, 
and lipid metabolism biomarkers compared to casein and whey-fed rats. There was no effect of CSP on 
inflammation; however, pro-inflammatory cyclooxygenase-2 was upregulated (p < 0.05) in adipose tissue 
of casein-fed rats which was balanced by upregulation of anti-inflammatory interleukin-10 response. 
Further, hepatic lipoprotein lipase was upregulated (p < 0.05) in rats consuming casein in response to 
cytokine production. RNA sequencing of hepatic tissue was performed to further investigate. 
Consumption of protein-free diet resulted in the greatest number (1,814) of differentially expressed genes 
compared to casein diet. Abundance of IGF-1 transcripts were greater (p < 0.05) in CSP and whey 
protein-fed rats. IGF-1 has been shown to illicit anabolic metabolism increasing the propensity for greater 
adiposity that was observed in whey-fed rats. 
 
Collectively, results indicate protein quality of CSP is comparable to casein. Based on studies 
investigating kidney and bone health and detailed studies on hepatic lipid metabolism and gene 
expression, providing low protein diets consisting of CSP as the protein source is a physiologically safe 
option and may be preferable to whey protein for preventing increased adiposity. Further, recovery of 
CSP from an invasive fish species could be marketed as a sustainable alternative to current commercial 
protein powders. 
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Chapter I 
Introduction 
As of 2016, the Fishes and Aquaculture Organization (FAO) reported global aquaculture 
growth declined by 3.3% meanwhile the human population continues to increase by 1.6%, 
annually, with an expected global population of 10 billion by 2050. Currently, fishery resources 
are operating either near optimal yield or at levels with elevated risk for fish stock depletion 
(FAO, 2016). A solution for overcoming limitations of natural fish resources is through 
utilization of less desirable fish species and nutrient dense fish processing by-products.  
Silver carp (Hypophthalmichthys molitrix) was imported to the United States in the 1970s for 
use as filter feeders in aquaculture. Since their unintentional introduction into the wild, silver 
carp are an invasive species causing decimation of freshwater ecosystems by out competing 
native fish species for phytoplankton. This resulted in negative impacts on the food chain in 
North American freshwater river systems (Chick, 2001). Yet, carp is composed of 7.13% fat, 
consisting mainly of the health beneficial long-chain omega-3 polyunsaturated fatty acids (n-3 
PUFAs) (Ljubojević et al., 2017), and 16.69% protein, comprising all the essential amino acids 
required by adults and children (Skibniewska, 2013). Silver carp’s abundance and nutritional 
composition makes it a sustainable fish species.  
Previous research reported that silver carp sarcoplasmic proteins solubilized in wash water 
can be recovered and freeze-dried into a protein-rich powder (Warren et al., 2018). However, the 
protein quality and safety of this novel protein supplement needs to be evaluated before CSP can 
be commercialized. Wibowo and colleagues (2007) compared sarcoplasm protein powder 
recovered by chitosan-alginate precipitation from surimi wash water to casein and commercial 
protein meals. Water soluble protein recovered from surimi wash water was determined to be 
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higher in protein quality than casein and commercial protein meals. Additionally, the recovered 
protein was considered safe based on an absence of significant changes in blood chemistry 
measurements after feeding 18% kcal protein to male rats aged 40 days for 20 days during the 
pubescent stage. In our study, reduced protein (10% kcal) diets and female rats were used to 
investigate whether lower protein content may reduce the risk of obesity and renal damage. 
However, low protein diets may be inadequate during the growth stage. 
Protein-energy malnutrition is defined as an imbalance between protein and energy intake 
and the amount required for optimal growth, development, and function (Fock et al., 2010; 
Bossola, 2015). Protein-energy malnutrition has been reported to alter liver histology and 
biochemical characteristics ultimately, leading to fatty liver and hepatic dysfunction (Caballero 
et al., 2015; Feres et al., 2010, Zutphen et al., 2016). When dietary protein content is reduced 
protein quality and digestibility becomes more important for sustaining growth and metabolic 
function. Koletzko and others (2009) found infants fed diets with lower inclusion of higher 
quality proteins reduced the risk of later in life obesity development. However, infant formulas 
often have higher protein content compared to human milk and have been related to weight gain 
and obesity later-in-life (Tang, 2018). Further, a European multi-centered clinical study reported 
infants receiving a high protein formula had a greater kidney volume compared to infants 
receiving a low protein formula or breastfed infants. Higher kidney volume was attributed to 
increased renal workload indicated by greater serum urea/creatinine ratios (Escribano et al., 
2011).  
Ong and others (2009) reported greater body weight gains in formula-fed infants compared to 
infants fed human milk due to increased insulin like growth factor 1 (IGF-1) and insulin 
excretion. Hepatic secretion of IGF-1 is dependent on nutritional status and hormones such as 
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insulin (Daughaday and Rotwin, 1989). Diets low in protein have been shown to decrease plasma 
concentrations of IGF-1 in growing pigs (Deng et al., 2007). While dietary branch chain amino 
acids (e.g. leucine, isoleucine, valine) have been reported to induce IGF-1 excretion. Wang et al. 
(2017) reported greater expression of IGF-1 from amino acid supplementation because of an 
interaction between mammalian target of rapamycin (mTOR), an important intracellular sensor 
for cell growth and autophagy, and peroxisome proliferator-activated receptor gamma (PPARγ), 
a transcription factor involved in the regulation of lipolysis. Song and others (2016) reported 
supplementation of protein sources from beef, chicken, pork and carp in the recommended 
amount (18% by weight) for seven days resulted in distinct gene expression and physiological 
responses. Carp protein consumption was shown to down-regulate genes regulating fatty acid 
oxidation and the synthesis of bile acids, triglycerides, and cholesterol with other proteins 
altering insulin secretion.  
Therefore, the objectives of this research project were:   
1) To evaluate the protein quality of CSP and effects of lower (10% kcal) protein diets on 
growth, body composition, renal markers, and bone health in a rat model.  
2) To assess low protein (10 % kcal) diets from CSP and two common commercial protein 
powders (casein and whey protein) effects on lipid metabolism in hepatic and adipose tissue 
compared to a protein-energy malnutrition diet. 
3) To investigate distinct phenotypic and hepatic transcriptome responses due to low protein 
(10% kcal) diets supplemented with CSP and milk proteins, casein and whey, in a growing 
animal model. 
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Chapter II 
Literature Review 
Literature Review 
1. Introduction  
As of 2016, global fisheries have been operating close to maximal levels risking depleting 
fish stock (FAO, 2016). According to the Fishes and Aquaculture Organization, expansion of 
aquaculture industries has decreased by 3.3 percent while the global population is expected to 
reach 10 billion by 2050 (FAO, 2016). Natural resources, such as fish stock, have innate 
limitations. However, solutions can be developed to overcome these innate limitations such as 
redirecting fish processing by-products or by using a less desirable fish species. 
Silver carp (Hypophthalmichthys molitrix) was initially brought into the United States during 
the 1970s as an algal control measure in aquaculture and sewage treatment ponds. Flooding in 
the 1980s resulted in the introduction of silver carp to the Mississippi River. Since their 
unintended introduction, silver carp have been reported in many rivers, lakes, and tributaries of 
the Mississippi River (Chick 2001). Due to a lack of natural predators in United States 
waterways, silver carp continue to spread into other habitats, severely disrupting existing 
ecosystems (Chick 2001). Despite their abundance, silver carp are underutilized due to their 
boniness that makes consumption and fish processing difficult. A proposed solution to the 
problem of overabundance of this invasive fish species is to use silver carp as a protein source 
for human consumption.  
Silver carp contain all 10 essential amino acids in quantities that are ideal for human needs 
(Ljubojević 2017). The protein and lipid composition of wild carp are 16.69% and 7.13%, 
respectively. Further, 72.64% of fatty acids consist of polyunsaturated fatty acids (PUFAs) with 
the health-beneficial omega-3 PUFAs (ω-3 PUFAs) being particularly abundant at 5.97% 
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(Ljubojević 2017). Previous research in our laboratory investigated the recovery, drying, and in 
vitro characteristics of a protein-rich silver carp sarcoplasmic protein powder; however, in vivo 
quality and safety was not considered (Warren et al. 2018).  
The purpose of this literature review is to provide an overview of the limited published 
studies that have investigated nutritional quality of aquatic proteins compared to other 
commercial sources. Additionally, studies focused on safety of low protein diets will be 
reviewed due to the initiative to reduce the protein content of infant formulas to prevent 
childhood obesity without causing protein energy malnutrition that can result in in stunted 
growth and NAFLD. 
2. Aquatic Protein Nutritional Quality  
The nutritional value of protein-peptide hydrolysate (PPH) material derived from hairtail 
fish was evaluated in a study by Ding and colleagues (2016). Soluble proteins were extracted 
from imitated surimi wash water then freeze-dried. The proximate composition of the surimi 
wash water showed the wash-water contained 8.19 ± 0.10 mg/ml dry matter, 0.54 ± 0.01 mg/ml 
(6.5%) lipid, and 6.68 ± 0.04 mg/ml (81.5%) crude protein. Water soluble proteins (2.26 ± 0.01 
mg/ml) were mainly composed of sarcoplasmic proteins. Flavoring compounds (aldehydes, 
ketones, alcohols, hydrocarbons, and heterocyclic compounds), oligopeptides and free amino 
acids, were the main components of the non-protein nitrogen (1.92 ± 0.01 mg/ml). There were no 
differences in crude protein concentration and dry matter between the initial surimi wash water 
(6.78 ± 0.04) and recovered PPH (6.74 ± 0.06 mg/ml). The composition of water-soluble 
proteins and nonprotein nitrogen for PPH was 2.81 ± 0.051 and 3.94 ± 0.064 mg/ml. This was 
higher than the water-soluble protein (2.26 ± 0.009 mg/ml) and non-protein nitrogen (1.92 ± 0.01 
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mg/ml) identified in the surimi wash water. This was attributed to the degradation of fish 
particles during hydrolysis.  
The recovered PPH contained all the essential amino acids needed by humans, which 
accounted for 44.1 % of total amino acids with total amino acid accounting for 78.2 % of the dry 
matter. High levels of nonessential amino acids were also detected in the recovered protein-
peptide material. The FAO/WHO essential amino acid requirements and comparison to whole 
egg protein were used to determine nutritional value. The amino acid score for the recovered 
PPH was greater than the FAO/WHO essential amino acid requirements. Methionine + cysteine 
was the first limiting amino acid. An essential amino acid index of 101.7 (>95), indicated that the 
recovered protein-peptide material has comparable nutritional value to standard whole egg 
protein. The biological value (BV) of the recovered PPH (BV 76.7) was greater than that of 
wheat (BV 67), peanuts (BV 59), and pork (BV 74) with beef (BV 76). Collectively, study 
results indicated that recovered PPH extracted from wash water possesses a high nutritional 
value (Ding et al., 2016). However, these protein quality calculations did not take the 
bioavailability of recovered proteins into account. 
Wibowo and others (2007) determine the safety and nutritional value of the recovered 
surimi wash water protein. Surimi wash water was collected, solids removed, and then treated 
with Chitosan-Alginate (Chi-Alg) to coagulate the soluble proteins in the wash water. Proximate 
composition and amino acid analysis were conducted on the freeze-dried recovered surimi wash 
water protein and compared to commercial protein meal sources. Proximate composition showed 
freeze-dried recovered protein had the higher crude protein content of 73.1 ± 1.67% (68.93% on 
wet basis) compared to herring, menhaden, soybean, and corn gluten meals, with 66.50%, 
58.86%, 43.21% and 62.45% protein on a wet basis, respectively.  
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Among the fish-based commercial protein meals, recovered surimi wash water protein 
had higher carbohydrate content (3.39%) compared to 1.3 and 2.9% reported in the herring and 
menhaden feeds, respectively. Lipid content in surimi wash water was 8.11% compared to 
herring and menhaden fish protein meals with 8.0 and 7.8% lipid, respectively. Surimi wash 
water protein had higher lipid content compared to soybean (3.1%) and corn gluten (1.7%) 
meals. Total reported essential amino acid for the surimi wash water protein and four protein 
meals were 51.8%, 35.4% (herring), 41.4% (menhaden), 25.4% (soybean), and 42.8% (corn 
gluten), repressively. The amino acid profile showed surimi wash water contained greater 
concentrations of all measured essential amino acids compared to herring, menhaden, soybean, 
and corn gluten commercial meal sources. The tryptophan content for surimi wash water protein 
and commercially available meals were not reported. Collectively, results indicated surimi wash 
water protein was nutrient rich and comparable to commercially available feed-protein sources, 
in terms of crude protein composition and essential amino acid content (Wibowo et al., 2007).  
Another study investigated recovery of protein from a novel source not using the Chi-Alg 
method. Protein was recovered from whole krill using isoelectric solubilization-precipitation 
producing a protein concentrate (Gigliotti et al., 2008). Krill (a species of pelagic crustaceans) 
are estimated to consist of the largest multi-cellular aquatic biomasses. Typically, krill consist of 
60 – 80% protein, 7 - 26% lipid, and 12 – 17% ash on a dry basis. Isoelectric solubilization 
precipitation recovered approximately 46% of protein from krill producing a protein concentrate 
composed of 77.7% protein, 8.1% lipid, and 4.4% ash (on a dry basis). The FAO/WHO/UNU 
amino acid requirements were used to compare the amino acids profile to human adult and infant 
requirements. All nine essential amino acids were present in sufficient amounts to meet the 
FAO/WHO/UNU amino acid requirements. Additionally, the krill protein concentrate contained 
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greater (p<0.05) amounts of protein and total essential amino acids compared to whole krill at 
531.5 mg/g and 212.1 mg/g, respectfully.  
Following amino acid evaluation of recovered protein, diets containing 10% krill protein 
concentrate or casein were fed to growing (age 28 d) female rats to characterize in vivo 
bioavailability and protein quality. No differences were found in body weight among the protein 
groups following four weeks of feeding. Results indicated krill protein concentrate was a 
complete protein comparable in quality to casein. No significant differences were reported 
among the protein quality measurements: true digestibility, biological value, net protein 
utilization, protein digestibility corrected amino acid score, and protein efficiency ratio. 
Collectively, results showed similar protein quality for krill protein concentrate and casein 
(Gigliotti et al., 2008).   
 Previous research in our laboratory investigated the effect of separation temperature on in 
vitro nutritional quality of a soluble protein derived from silver carp (Warren et al., 2018). Water 
soluble proteins were recovered from homogenized silver carp using dilution, homogenization, 
and centrifugation. The recovered protein wash water was freeze-dried and powdered for 
analysis. The recovered silver carp sarcoplasmic protein powder (CSP) contained approximately 
82% protein, 4% lipid and 15% ash. The high mineral content was due to minerals commonly 
stored in bone and cartilage being release during homogenization.  
Fatty acid profiling showed CSP contained mainly saturated fatty acids (31%) and 
monounsaturated fatty acids (27%) with polyunsaturated fatty acids composing 13% of total 
lipids. The amino acid profile of the CSP was compared to the FAO/WHO/UNU adult and infant 
amino acid requirement. CSP met all amino acid requirements for adults; however, amino acid 
requirements set for infants were not met due to low contents of some branched chain amino 
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acids (isoleucine and leucine) and sulfur amino acids (cysteine and methionine). Warren et al. 
(2018) suggested proteins derived from silver carp could be a nutritious source of amino acids 
and micronutrients. However, these data do not consider safety or bioavailability of the protein 
powder. Collectively, results of these studies indicate protein derived from aquatic sources are 
nutritious; however, bioavailability and safety also need to be addressed.   
3. Proteins and Renal Health 
For approval of commercial use, the safety of novel protein supplements must be evaluated. 
Studies have found an association between protein consumption and the development of renal 
disease (Friedman, 2004). Consumption of chronic and acute high protein diets showed an 
increase in glomerular filtrations rates and renal blood flow, increasing risk of kidney stress and 
potential for renal damage (Martin et al., 2005). In the clinical setting, individuals diagnosed 
with renal disease are advised to follow a standard dietary recommendation is to restrict the 
consumption of proteins (Martin et al., 2005). A study consisting of participants with no prior 
history of kidney disease found estimated glomerular filtration rate (eGFR) increased (p<0.05) in 
participants consuming a diet in which 10% of kilocalories from carbohydrates were replaced by 
protein (referred to as a protein emphasized diet). The eGFR scores were higher in participants 
consuming the protein emphasized diet as compared to diets with elevated carbohydrate and 
unsaturated fat diets. Due to potential health risks to participants, the study was discontinued and 
therefore, unable to analyze the effects of long-term, high protein diets (Juraschek et al., 2013).  
The effects of a high and low protein intake on kidney health was investigated in a European 
multi-centered clinical study. Participants consisted of formula-fed infants (n=601) enrolled in a 
1-year long program and randomly assigned to either a low-protein (1.94 ±0.46 g/kg) or high-
protein (3.0 ±0.7 g/kg per day) formula (Escribano et al., 2011). Results indicated infants 
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receiving the high protein formula had greater (p<0.05) kidney volumes, serum urea, and urea to 
creatinine ratios compared to infants receiving a low protein formula or breastmilk. Higher 
kidney volume was attributed to the increased renal workload indicated by greater serum 
urea/creatinine ratios. There were no differences were found among infants fed the low-protein 
formula compared to breast-fed infants (Escribano et al., 2011). Due to ethical consideration in 
conducting studies using infant and growing children, studies have mainly evaluated 
consumption of proteins from different sources on renal health using animal models.  
Diet-induced nephrocalcinosis is a common occurrence in female rats (Rao, 2002). The 
transition of nephrocalcinosis to nephrolithiasis was implicated in nephropathy and subsequent 
renal failure in rats (Jara et al., 2004). Gigliotti et al. (2008) compared feeding a low protein 
(10% kcal) diets consisting of krill protein concentrate and casein to growing female rats. Rats 
fed krill protein concentrate consumption had lower (p < 0.05) kidney weights compared to 
casein.  Additionally, total renal mineral content was lower (p < 0.001) in rats fed krill protein 
concentrate (0.07 g/g kidney) compared to rats fed casein (0.3 g/g kidney). The study results 
suggested feeding different protein sources influenced mineral deposition in the kidney with krill 
protein concentration reducing renal calcification. Gigliotti et al. (2010), further investigated the 
pathogenesis of renal mineralization and renal calcium deposition in casein fed rats found krill 
protein concentrate prevented early renal injury by modulating urinary n-acetyl glucosaminidase 
activity, renal mineralization, and proteinuria while improving glomerular filtration rates. In 
addition to protein, other bioactive nutrients in the krill protein concentrate, ω-3 PUFAs, also 
appeared to have renal protective effects. Collectively, the studies by Gigliotti and colleagues 
(2008; 2010) provided evidence that low protein diet consisting of aquatic sourced proteins 
attenuated diet-induced renal injury and improved function.  
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Zhang and Beynan (1992) supplemented growing female rats protein diets sourced from 
soybean, casein, or cod meal at doses consisting of 2.40, 4.79 or 7.19 g nitrogen/100 g for 3 
weeks. Lower kidney calcium concentrations (p<0.05) were found in rats fed cod meal compared 
to soybean and casein-fed rats. Furthermore, evidence of nephrocalcinosis was absent when renal 
histology was examined indicating consumption of cod meal had minimal effects of renal health.  
Wibowo et al. (2007) compared sarcoplasmic protein powder recovered by chitosan-alginate 
precipitation from surimi wash water to casein and commercial protein meals. While protein 
recovered from surimi wash water was determined to be higher in protein quality than casein and 
commercial protein meals, residual chitosan has been associated with safety issues such as 
enlargement of the kidneys. Consumption of surimi wash water extracted with chitosan resulted 
in greater (p<0.05) final kidney weights compared to the standard casein and casein-chitosan 
diets group of 1.4g, 1.2g and 1.2g, respectfully. Although renal histology and mineral content 
was not quantified; there were no significant differences in blood biomarkers kidney functions. 
These results support the safety of surimi wash water protein recovered using chitosan-alginate 
precipitation (Wibowo et al., 2007). Collectively, studies provide support for safety and 
potentially protective effects of aquatic protein consumption on renal health. To the best of our 
knowledge, no studies have been conducted to determine the safety of carp derived sarcoplasmic 
protein recovered from wash water on renal health.  
Another safety concern is kidney damage as it reduces the body’s ability to buffer acids 
produced during protein metabolism. Particularly, sulfur amino acids may cause skeletal tissue to 
liberate its calcium stores which alters the structural rigidity of bone (Cuenca-Sanchez et al., 
2015). Therefore, it is important to evaluate the effect of consuming protein from novel sources 
on bone health. 
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4. Protein and Bone Health 
Both high and low protein diets can be detrimental for bones. When high protein diets are 
consumed, the kidneys may be unable to neutralize the acid load produced in amino acid 
metabolism. In order to buffer increased acid load, bone release stored carbonate and calcium 
which can affect long-term bone health (Cuenca-Sanchez et al., 2015). Subsequently, release of 
calcium stores from bone and increased calcium excretion results in bone loss which increases 
the risk of osteoporosis (Cuenca-Sanchez et al., 2015).  
Low protein diets may also be detrimental to bones. Kerstetter and colleagues (2003) 
reported low dietary protein intake correlated with reduced bone density and increased rates of 
bone loss. Further, reduced bone density and structure during the growth and development stage 
increases risk of osteoporosis in adulthood (Gordon et al., 2017).  
Animal models have been used to evaluate novel protein sources. Rats fed 10% krill protein 
concentrate and casein showed no differences in bone morphometry and bone strength (Gigliotti 
et al., 2010). These results may be due to krill protein concentrate containing high concentrations 
of calcium and phosphorous. Calcium and phosphorous are critical for formation of 
hydroxyapatite which provide mechanical resistance of the organic bone matrix (Bonjour, 2011). 
Similarly, Fournier et al., (2014) fed low protein (5% kcal casein) diets containing calcium 
(0.2%) and phosphorous (0.16%) to growing Sprague-Dawley female rats for eight weeks. 
Results indicated supplementation of calcium and phosphorous attenuated the reduction in bone 
mass and strength typically related to low protein diet consumption.  
Dietary protein is metabolized to urea for excretion by the kidneys (Friedman, 2004) and 
therefore, high protein intakes may contribute to both kidney and liver injury and over the long 
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term reduced function. Alternatively, protein energy malnutrition has been observed to cause 
fatty liver (Kumar et al.,1972).  
5. Non-Alcoholic Fatty Liver Disease  
Non-alcoholic fatty liver disease (NAFLD) is defined as steatosis of the liver that is not 
caused by alcohol consumption. NAFLD among of the most prevalent liver diseases in adults 
worldwide. Additionally, the prevalence of NAFLD in children is also increasing (Munteanu et 
al., 2016; Temple et al., 2016). NAFLD is diagnosed by light microscopic examination of  
hematoxylin and eosin stained liver sections (4–5 μm thick) showing fat vacuoles in > 5% of 
hepatocytes (Sanyal et al., 2011).  
The dysregulation of hepatic lipid metabolism is illustrated in Figure 1 (Millar et al., 2013). 
Briefly, the mechanism in NAFLD may be due to enhance de novo lipogenesis (DNL) by 
nutrients stimulating transcription factors involved in the DNL pathway (Strable et al 2010; Naik 
et al., 2013). Fatty acid synthetase (FAS) is activated by transcription factor sterol regulatory 
binding protein-1c (SREBP-1c) and carbohydrate element response binding protein (ChREBP). 
FAS produces saturated fatty acids and stearoyl-CoA desaturase (SCD-1) removes hydrogens 
from saturated fatty acids producing monounsaturated fatty acids (MUFAs). De novo synthesized 
fatty acids are used for synthesis of triglycerides. The rate limiting enzyme in by de novo 
synthesis of triglycerides is diacylglycerol O-acyl transferase-2 (DGAT2). Endogenous 
triglycerides either remain in the liver, or following activation of microsomal triglyceride 
transport protein (MTTP) are transported to extrahepatic tissue in very-low density lipoprotein 
(VLDL). In the circulation, VLDL interact with lipoprotein lipase (LPL) in peripheral tissues 
such as adipose tissue. LPL removes triglycerides from VLDL to be used in energy production or 
for storage (Feingold et al., 2018). 
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While the etiology of NAFLD is often associated with poor diets containing high amounts of 
saturated fatty acids and simple carbohydrates, dietary protein has also been shown to affect 
NAFLD. In 1972, Kumar et al. (1972) reported rhesus monkeys provided protein restricted diets 
developed fatty liver due to enhanced hepatic triglycerides and had reduced serum triglycerides 
and phospholipids. Results indicated protein deficient diets impair secretion of hepatic 
triglycerides as VLDLs. In the absence of dietary protein, de novo protein synthesis is inhibited. 
In turn, this decreases VLDL production and transport resulting in increased hepatic lipid 
accumulation (Kumar et al., 1972). In a more recent study, Zutphen et al. (2016) fed growing rats 
low protein (5% kcal) diets to assess peroxisomal and mitochondrial dysfunction as a potential 
underlying mechanism in malnutrition induced NAFLD. Results showed hepatic steatosis and 
hypoalbuminemia was accompanied by reduced peroxisome number and mitochondria activity 
which impaired hepatic ATP production through oxidation of fatty acids (Zutphen et al., 2016). 
In contrast, high protein and low carbohydrate diets prevent hepatic fat deposition by stimulating 
carbohydrate metabolism, DNL, and lipid transport (Kargulewicz et al., 2014).  
Duarte et al. (2014) reported providing high protein and low carbohydrate diets to adults with 
NAFLD reduced VLDL and low density lipoprotein (LDL) concentrations, enhanced high 
density lipoprotein (HDL), and improved liver damage biomarkers. Additionally, protein source 
has been shown to affect NAFLD progression. Kani et al. (2014) found providing NAFLD 
patients a low calorie and low carbohydrate diets containing soy protein improved biomarkers of 
liver damage, but lipid profiles were not affected. Similarly, soy protein supplementation 
reduced plasma cholesterol and hepatic triglyceride deposition while enhancing insulin 
sensitivity and antioxidant capacity in rats (Yang et al., 2011).  
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Given the limited number of studies, additional research is needed to determine the role 
dietary protein amount and source on liver health and disease pathogenesis. This is important 
because untreated NAFLD can progress to non-alcoholic steatohepatitis (NASH) indicated by 
inflammation in as well as liver steatosis (Michelotti et al., 2013). It is estimated that 25% of the 
world’s population has NAFLD with a quarter of those individuals having NASH (Diehl et al., 
2017). A multiple-hit model has been used to explain the progression of NAFLD, initiated by fat 
accumulation in the liver followed by the onset of inflammation (Buzzetti et al., 2016). The 
immune system is implicated in a variety of diseases, including those associated with poor diet.  
Therefore, we will also introduce the major inflammatory markers pertaining to diet-induced 
diseases.     
6. Inflammatory Markers  
Interleukin 10 (IL-10) and tumor necrosis factor alpha (TNF-α) are often referred to as “the 
good” and “the ugly” cytokines, respectively (Stenvinkel et al., 2005). IL-10 is suggested to be 
the most important anti-inflammatory cytokine with secretion typically followed by a 
proinflammatory signal by a few hours (Stenvinkel et al., 2005). TNF-α is multifaceted with 
roles in lipid metabolism, coagulation, insulin resistance, and endothelial dysfunction. However, 
TNF-α is proposed to be the master regulator of cytokines (Stenvinkel et al., 2005). TNF- α and 
the transcription factor, nuclear factor kappa-light enhancer of activated B cells (NFκB), are key 
regulators in COX-2 expression. COX-2 catalyzes the conversion of arachidonic acid to pro-
inflammatory prostaglandins that play a significant role to the pathology of several diseases (Lee 
at al., 2015; Lim et al., 2001).  
NAFLD has been shown to stimulate inflammatory gene expression, through activation of 
transcription factor NFκB (Milanski et al., 2009). NFκB is involved in the activation of 
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downstream inflammatory cytokines, such as interleukin 6 (IL-6) and TNF-α, resulting in 
increased inflammation in the liver (Buzzetti et al., 2016; O’Neill et al., 1997). This 
inflammatory cascade is not limited to the liver. The inflammatory process was also implicated 
in adipose tissue. Lipogenesis resulting from alterations in fatty acid and glucose metabolism 
result in changes in fatty acid profiles of stored lipids in adipose tissue and inflammation status. 
This state can further exacerbate increased hepatic DNL in NAFLD patients (Musso et al., 2012; 
Burhans et al., 2016; Tamura et al 2015). When mitochondria and peroxisomes are overloaded 
by increased lipid production, lipid derived reactive oxygen species (ROS) are produced which 
activate inflammatory pathways (Buzzetti et al., 2016). Cusi (2009) reported ROS, together with 
oxidized lipoproteins, may activate Kupffer and hepatic stellate cells, which lead to additional 
inflammation and fibrosis. Further, increased generation of reactive oxygen species and 
inflammation from free fatty acid metabolism promotes NAFLD progression to more severe 
NASH (Michelotti et al., 2013). 
The relationship between protein malnutrition and NAFLD has not been well-studied. Protein 
malnutrition has been shown to increase inflammatory reactivity that may contribute to 
development of NAFLD and edema (Sauerwein et al., 1997). Plasma concentrations of mediators 
of the inflammatory cascade were assessed in children identified with protein energy 
malnutrition. Children with protein energy malnutrition exhibited greater (p<0.05) serum 
concentrations of IL-6, C-reactive protein, and soluble receptors of tumor necrosis factor alpha 
(sTNFR-p55 and sTNFR-p75). However, no significant differences were reported in serum IL-1 
concentrations among patients with or without protein energy malnutrition. Further, serum 
concentrations of antioxidants (glutathione and vitamin E) was used to assess antioxidant status. 
Patients with protein energy malnutrition had lower (p<0.05) levels of circulating antioxidants. 
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Collectively, results from this study showed protein energy malnutrition increased inflammatory 
and ROS reactivity in children suggesting enhanced inflammatory and oxidative stress may 
contribute to NAFLD (Sauerwein et al., 1997). High protein diets rather than protein energy 
malnutrition are common in developed countries. However, high protein consumption has been 
implicated as a risk factor contributing to the increasing prevalence of childhood obesity in 
Western countries.    
7. Infant Nutrition and Protein  
Cow-milk-based infant formula is widely used in developed countries as a substitute for 
breastmilk when breastfeeding is not possible. Infant formulas often have higher protein content 
compared to human breast milk of ~2.2 g/100 kcal and ~1.5 g/100 kcal, respectfully. This 
discrepancy has been associated with weight gain in formula-fed infants and to obesity later-in-
life (Tang, 2018). This “early protein hypothesis” suggests that a higher protein intake through 
infant formulas increase circulating branch chain amino acids (leucine, isoleucine, and valine) 
and other essential amino acids, which stimulate the secretion of insulin and insulin-like-growth 
factor 1 (IGF-1) that promotes weight gain in formula-fed infants (Tang, 2018).  
In a longitudinal study, formula-fed infants (n=1138) were randomly assigned to lower 
protein (1.77 - 2.2 g protein/100 kcal) or high protein (2.9 - 4.4 g protein/100 kcal) groups for the 
first two years of life (Koletzko et al., 2009). There was no significant differences in infant 
length among the diet groups. However, infants consuming lower amounts of high-quality 
protein had reduced risk of weight gain and later risk of obesity compared to infants fed a high 
protein diet (Koletzko et al., 2009). Marsh et al. (2016) used health economic modeling to 
predict the long-term economic outcomes of lower protein infant formulas compared to higher 
protein formulas. The model predicted lower (p<0.05) lifelong body mass index and incidence of 
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obesity in individuals fed low protein infant formula. Therefore, reduce healthcare costs and 
improve population productivity were predicted for infants provided lower protein infant 
formulas.  
The effects of low protein intake during infancy on body composition and safety has not been 
extensively assessed, raising safety concerns about adequate growth and maturation (Patro-Golab 
et al., 2016). Therefore, protein sources with amino acids profiles containing all 10 essential 
amino acids in high amounts to promote growth by stimulating maximal protein synthesis are 
required. 
8. Metabolism of Branched Chain Amino Acid  
Branched chain amino acids (BCAAs) are composed of valine, leucine, and isoleucine. 
BCAAs make up approximately 40% of the required essential amino acids in humans. Further, 
the essential amino acids in muscle proteins are comprised of approximately 35% BCAA 
(Harper et al., 1984). Circulating levels of BCAAs are highly regulated by systems with rapid 
responses to excess or deficient conditions.  
Figure 2 provides the pathway of BCAA catabolism. Skeletal muscle is considered a primary 
site for BCAA catabolism due to high concentrations of branched chain aminotransferase 
(BCAAAT) (O’Connell, 2013). BCAAAT catalyzes the reversible transamination of BCAAs 
producing branched chain ketoacids (BCKAs) in the cytosol of cells. BCKAs are transported into 
the mitochondria through the carnitine shuffle. In the mitochondria, BCAAs are degraded by 
branched chain alpha-keto acid dehydragenase (BCAKADH), to produce BCKAs, that undergo 
oxidative decarboxylation. Coenzyme A compounds are produced and further oxidized to form 
acetyl CoA and succinyl CoA. These products then enter the citric acid cycle for use in energy 
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production (O’Connell, 2013). However, proteins play a minor role in energy production in the 
body. 
Instead BCAA catabolism is important in the production of additional amino acids such as 
glutamine and alanine. Glutamine serves as a bioenergetic substrate for cell growth and is found 
in the highest amount of all amino acids circulating in blood (DeBerardinis et al., 2010). 
Glutamate is the primary nitrogen donor in the synthesis of nonessential amino acids and is used 
as a signaling molecule in the regulation of cell proliferation by supporting energy production by 
entering the citric acid cycle. Additionally, glutamine can be converted to glutamate by the 
removal of an amino group catalyzed by glutaminase when needed for energy production.  
Alanine is utilization in protein synthesis, glucose production in the liver for gluconeogenesis 
and participates in the glucose alanine cycle during starvation. Alanine produced from BCAAs is 
transported to the liver for glucose production (O’Connell et al., 2013). Subsequently, dietary 
protein and BCAAs act as signaling molecules to modulate energy metabolism to sustain 
homeostasis within the body. Studies have reported increased secretion of insulin like growth 
factor 1 (IGF-1) potentiates greater body weight gains in infants fed whey-based formulas high 
in BCAAs (Ong et al.,2009). Therefore, the next section provides an overview of IGF-1. 
9. IGF-1: Role & Signaling 
 IGF-1, secreted mainly from the liver, is considered a somatomedin that regulates animal 
growth and metabolism by mediating growth hormone (Daughaday et al., 1989; Ohlsson et al., 
2009). Synthesis of IGF-1 is dependent on both nutritional status and concentrations of 
circulating hormones, insulin and growth hormone. Serum IGF-1 concentrations are highly 
regulated and mediated by IGF binding proteins family and acid-labile subunit (O’Connell et al., 
2013). Figure 3, illustrates the IGF-1 dependent pathway for upregulating anabolic metabolism 
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through the activation of mammalian target of rapamycin complex 1 (mTORC1) (O’Connell et 
al., 2013).  
Phosphatidylinosotide 3-kinase and protein kinase B are activated by IGF-1 and insulin, 
resulting in phosphorylation of tuberous sclerosis protein 2 (TSC2). This attenuates the inhibition 
of the TSC1/TSC2 complex, activating the Ras homolog enriched in brain (Rheb) leading to the 
final activation mTORC1. Three downstream transcription factors of mTORC1 are critical for 
anabolism: ribosomal protein S6 kinase 1 (S6K1), SREBP, and eukaryotic translation initiation 
factor 4E binding protein 1 (4EBP1). S6K1 and SREBP lead to synthesis of proteins and lipids, 
respectively while 4EBP1 enhances mRNA translation and growth (O’Connell, 2013) 
The role of amino acids in the induction of IGF-1 secretion has not been well-studied. 
However, recently, Wan et al. (2017) provided pigs a normal protein diets (20% kcal protein) or 
low protein diets (14% kcal protein) to determine the role of dietary protein has on IGF-1 
expression, secretion, and subsequent hepatic transcriptome alterations. Serum IGF-1 and IGF-1 
expression were greater (p<0.05) in pigs fed a normal protein diet compared to a low protein 
diet. Additionally, RNA sequencing identified 1,319 genes that were differentially expressed 
among the diet groups with pathway analysis reporting PPAR pathway to be among the 
stimulated pathways.  
IGF-1 expression was dependent on amino acid concentration and PPARγ in porcine primary 
hepatocyte models. Dosing with greater amino acid concentrations resulted in upregulation (p < 
0.05) of IGF-1 and PPARγ gene expression. Further, amino acid induced IGF-1 expression was 
reversed by PPARγ knocked down in HepG2 cells. Collectively, results indicated PPARγ plays 
an important role in IGF-1 response to dietary protein (Wan et al, 2017). Global gene expression 
profiles of hepatic transcriptome have the potential to identify the effect of novel dietary protein 
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on pathways and gene alterations. This is important given the central role of the liver in 
toxicology as well as in many aspects of whole-body physiology. 
 
10. Effect of Protein Source on Hepatic Transcriptome  
Protein sources have been shown to have significant effects on metabolism. Meat and meat 
products provide excellent sources of high-quality proteins, indicated by high biological values, 
amino acid scores and digestibility, as well as content of micronutrients required for life-long 
health (McNeill et al., 2012; Pereira et al., 2013). Fish protein has been suggested to improve 
insulin sensitivity (Song et al, 2016). However, research on the effect protein source has on 
physiological and gene-expression responses is limited.  
Song and colleagues (2016) investigated the effect of dietary protein source on hepatic 
transcriptome. Male rats (age 28 days) were fed adequate (18 % kcal) protein diets based on the 
AIN-93G diet with protein sourced from beef, pork, chicken, fish (carp), and casein for 7 days. 
Following 7 days of feeding, rats were euthanized, livers were dissected, and serum was 
collected for serum biomarker assessment and amino acid profiling. Casein-fed rats were used as 
the control for all analyses. Results showed total plasma amino acid concentrations were greater 
(p<0.05) for all proteins except pork. However, pork protein reduced (p<0.05) adiposity and 
hepatic triglycerides concentrations. Fish protein consumption attenuated serum total cholesterol. 
  Liver transcriptome response was also investigated. Results showed rats fed pork had the 
lowest number of differentially expressed genes at 609 genes, while rats fed chicken had the 
largest number of significantly expressed genes at 1258. Pathway analysis using conservative 
significant thresholds (p<0.05; false discovery rate (FDR)<0.25) indicated transcriptome 
response from rats consuming chicken and beef were comparable to casein. Interestingly, fish 
consumption resulted in the greatest number of pathway response alterations. All meat proteins 
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enhance expression of antigen production, intracellular trafficking, and oxidoreductive-
transformation pathways while suppressing signal transduction and mitochondrial biogenesis. 
Pork was the only protein source to suppress lipid and amino acid metabolic pathways while 
both fish and beef protein sources induced amino acid transport. Additionally, fish consumption 
was the only protein source that reduced nuclear-transport and cofactor metabolism.  
Many of the observed differences were attributed to the difference in concentrations of 
leucine among the protein diets. Leucine has been suggested to mediate the activation of 
mTORC and its role in the activation of transcript factors involved in protein synthesis, lipid 
biosynthesis, and cell growth (O’Connell, 2013). Collectively, study results suggested distinct 
physiological, metabolism and gene expression responses can be implemented in rats fed diets 
containing different protein sources. However, metabolism changes with age, gender, and dietary 
protein content and sources. Song and colleagues (2016) investigated 18 % kcal protein diets 
derived from carp muscle (sarcoplasmic and myofibrillar proteins). To our knowledge, no studies 
have investigated the effects of a 10 % kcal protein diet derived from carp sarcoplasm protein on 
global and hepatic gene expression.    
In reviewing the literature, few studies have investigated the nutritional quality of aquatic 
proteins compared to other commercial sources or specifically investigated in vivo safety and 
effects on metabolism. Additionally, most studies focused on safety of high or normal protein 
intake despite the prevalence of stunted growth and NAFLD due to protein energy malnutrition 
in many countries. Further, in Western countries there is an initiative to lower protein content in 
infant formulas to reduce risk of childhood obesity. This has led to research discoveries for a 
cost-effective and sustainable source of high quality protein that adequately supports growth and 
is safe when fed at lower levels.   
26 
 
11. References 
1. Alrefai WA, Gill RK. (2007). Bile Acid Transporters: Structure, Function, Regulation 
and Pathophysiological Implications. Pharm Res. 24(10), 1803-1823. 
doi:10.1007/s11095-007-9289-1 
2. Bonjour, J. (2011). Calcium and Phosphate: A Duet of Ions Playing for Bone Health. 
Journal of the American College of Nutrition. 30, 438S-448S. 
http://doi:10.1080/07315724.2011.10719988. 
3. Browning JD, Horton JD. (2004). Molecular mediators of hepatic steatosis and liver 
injury. J Clin Invest.114(2):147-152. doi:10.1172/JCI22422 
4. Burhans MS, Ntambi JM. (2016). Monounsaturated Fatty Acid Mediated Liver-Adipose 
Tissue Crosstalk and Metabolic Regulation. In: Hepatic De Novo Lipogenesis and 
Regulation of Metabolism. Cham: Springer International Publishing, 255-265. 
doi:10.1007/978-3-319-25065-6_12 
5. Buzzetti E, Pinzani M, Tsochatzis EA. (2016). The multiple-hit pathogenesis of non-
alcoholic fatty liver disease (NAFLD). Metabolism. 65(8), 1038-1048. 
doi:10.1016/J.METABOL.2015.12.012 
6. Chick, JH. (2001). Invasive Carp in the Mississippi River Basin. Science. 292, 2250–
2251. http://doi:10.1126/science.292.5525.2250. 
7. Cuenca-Sanchez, M, Navas-Carrillo D, Orenes-Piñero E. (2015). Controversies 
Surrounding High-Protein Diet Intake: Satiating Effect and Kidney and Bone Health. 
Advances in Nutrition: An International Review Journal, 6(3), 260–266. 
doi:10.3945/an.114.007716. 
27 
 
8. Cusi K. (2009). Nonalcoholic fatty liver disease in type 2 diabetes mellitus. Curr Opin 
Endocrinol Diabetes. Obes 16, 141–9. 
9. Daughaday WH, Rotwein P. Insulin-like growth factors I and II. Peptide, messenger 
ribonucleic acid and gene structures, serum, and tissue concentrations. Endocr Rev. 1989; 
10(1), 68–91. Epub 1989/02/01. doi: 10.1210/edrv-10-1-68 
10. DeBerardinis, RJ, Cheng, T. Q. (2010). The diverse functions of glutamine in 
metabolism, cell biology and cancer. Oncogene, 29, 313–324. 
11. Diehl AM, Day C. (2017). Cause, Pathogenesis, and Treatment of Nonalcoholic 
Steatohepatitis. Longo DL, ed. N Engl J Med. 377(21), 2063-2072. 
12. Ding, H., Li, D., Wei, X., Huang, Y., Cui, S., Xie, H., & Zhou, T. (2016). Protein-peptide 
nutritional material prepared from surimi wash-water using immobilized chymotrypsin-
trypsin. Journal of the Science of Food and Agriculture J. doi:10.1002/jsfa.7969 
13. Duarte SMB, Faintuch J, Stefano JT, Oliveira, MB, Mazi DF, Rabelo F. (2014). 
Hypocaloric high-protein diet improves clinical and biochemical markers in patients with 
nonalcoholic fatty liver disease (NAFLD) Nutricion hospitalaria. 29, 94–101. 
14. Escribano, J, Luque, V, Ferre, N, Zaragoza-Jordana, M, Grote, V., Koletzko, J, 
Gruszfeld, D, Socha, P, Dain, A., Van Hees, J., Verduci, E., Closa-Monasterolo, R. 
(2011). Increased Protein Intake Augments Kidney Volume and Function in Healthy 
Infants. Kidney International. 79, 783-790. http://doi:10.1038/ki.2010.499. 
15. FAO, Food and Agriculture Organization of the United Nations. (2016). The State of 
World Fisheries and Aquaculture, 2016. Rome, Italy: Author. Retrieved from 
https://www.fao.org/3/a-i5555e.pdf. 
28 
 
16. Feingold, KR, Grunfeld, C. (2018). Introduction to Lipids and Lipoproteins. Endotext 
[Internet].  
17. Fournier, C, Rizzoli, R, Ammann, P. (2014). Low Calcium-Phosphate Intakes Modulate 
the Low-Protein Diet-Related Effect on Peak Bone Mass Acquisition: A Hormonal and 
Bone Strength Determinants Study in Female Growing Rats. Endocrinology, 155(11), 
4305-4315. http://doi: 10.1210/en.2014-1308. 
18. Friedman, AN. (2004). High-protein diets: potential effects on the kidney in renal health 
and disease. Am J Kidney Dis. 44(6), 950-962. 
19. Gigliotti, J, Jaczynski, J, & Tou, J. (2008). Determination of the Nutritional Value, 
Protein Quality and Safety of Krill Protein Concentrate Isolated using an Isoelectric 
Solubilization/Precipitation Technique. Food Chemistry, 111(1), 209–214. 
http://doi.org/10.1016/j.foodchem.2008.03.030. 
20. Gigliotti, JC, Smith, AL, Jaczynski, J, & Tou, J C. (2010). Consumption of Krill Protein 
Concentrate Prevents Early Renal Injury and Nephrocalcinosis in Female Sprague–
Dawley Rats. Urological Research, 39(1), 59–67. http://doi.org/10.1007/s00240-010-
0261-x. 
21. Gordon, CM, Zemel, BS, Wren, TA, Leonard, MB, Bachrach, LK, Rauch, F, Gilsanz, V, 
Rosen, CJ, Winer, KK. (2017). The Determinants of Peak Bone Mass. Journal of 
Pediatrics, 180, 261-269. http://doi: 10.1016/j.jpeds.2016.09.056. 
22. Harper, AE, Miller, RH, Block, KP. (1984). Branched-chain amino acid metabolism. 
Annu. Rev. Nutr. 4, 409–454. 
23. Jara, A., Chacon, C., Ibaceta, M., Valdivieso, A., Felsenfeld, A. (2004). Effect of 
Ammonium Chloride and Dietary Phosphorus in the Azotaemic Rat. Part II-Kidney 
29 
 
Hypertrophy and Calcium Deposition. Nephrology Dialysis Transplantation, 19(8), 
1993–1998. http://doi.org/10.1093/ndt/gfh301. 
24. Juraschek, Stephen P, Appel LJ, Anderson CA, Miller ER. (2012). Effect of a High-
Protein Diet on Kidney Function in Healthy Adults: Results From the OmniHeart Trial. 
American Journal of Kidney Diseases, vol. 61(4), 547–554. 
doi:https://dx.doi.org/10.1053/j.ajkd.2012.10.017. 
25. Kani AH, Alavian SM, Esmaillzadeh A, Adibi P, Azadbakht L. (2014). Effects of a novel 
therapeutic diet on liver enzymes and coagulating factors in patients with non-alcoholic 
fatty liver disease: A parallel randomized trial. Nutrition. 30, 814–21. 
26. Kargulewicz A, Stankowiak-Kulpa H, Grzymisławski M. (2014). Dietary 
recommendations for patients with nonalcoholic fatty liver disease. Przegla̜d 
Gastroenterologiczny. 9, 18–23. 
27. Kerstetter, JE, O’Brian, KO, Insogna, KL. (2003). Dietary Protein, Calcium Metabolism, 
and Skeletal Homeostasis Revisited. The American Journal of Clinical Nutrition, 78(3). 
doi:10.1093/ajcn/78.3.584s. 
28. Koletzko, B, von Kries, R, Closa, R., Escribano, J, Scaglioni, S, Giovannini, M, Beyer, J, 
Demmelmair, H, Gruszfeld, D, Dobrzanska, A, Sengier, A, Langhendries, J, P, Rolland 
Cachera M, F, Grote, V. (2009). Lower Protein in Infant Formula is Associated with 
Lower Weight up to age 2 y: a Randomized Clinical Trial. American Journal of Clinical 
Nutrition, 89, 1836-1845. http://doi.org/10.3945/ajcn.2008.27091. 
29. Kumar V, Deo MG, Ramalingaswami V. (1972) Mechanism of Fatty Liver, in Protein 
Deficiency. Gastroenterology, 62(3), 445-451. doi: 10.1016/S0016-5085(72)80153-7 
30 
 
30. Lee, Y, Yang, Y, Huang, P, Li, W, Huang, M, Kao, C, Chenag, Y, Chen. M. (2015). 
Exercise suppresses COX-2 pro-inflammatory pathway in vestibular migraine. Brain 
Research Bulletin. 116, 98-105. https://doi.org/10.1016/j.brainresbull.2015.06.005 
31. Li T, Chiang JYL. Bile acid signaling in metabolic disease and drug therapy. Pharmacol 
Rev. 2014, 66(4), 948-983. doi:10.1124/pr.113.008201 
32. Lim J, Kim H, Kim K. (2001). Nuclear factor-kappaB regulates cyclooxygenase-2 
expression and cell proliferation in human gastric cancer cells. Lab Invest. 81(3), 349-60. 
33. Ljubojević, D, Đorđević, V, & Ćirković, M. (2017). Evaluation of Nutritive Quality of 
Common Carp, Cyprinus carpio L. IOP Conference Series: Earth and Environmental 
Science, 85, 012013. http://doi.org/10.1088/1755-1315/85/1/012013. 
34. Marsh, K., Moller, J., Basarir, H., Orfanos, P., Detzel, P. (2016). The Economic Impact 
of Lower Protein Infant Formula for the Children of Overweight and Obese Mothers. 
Nutrients. 8(1), E18. http://doi.org/10.3390/nu8010018. 
35. Martin, W, Armstrong, L, Rodriquez, NR. (2005). Dietary protein intake and renal 
function.  Nutrition and Metabolism, 2(25), 121–140. doi:10.1201/b16308-10. 
36. McNeill, S., Van Elswyk, ME., (2012). Red meat in global nutrition. Meat Sci. 92, 166–
173. 
37. Michelotti GA, Machado MV., Diehl AM. (2013). NAFLD, NASH and liver cancer. Nat 
Rev Gastroenterol Hepatol. 10(11), 656-665. doi:10.1038/nrgastro.2013.183 
38. Milanski M, Degasperi G, Coope A (2009). Saturated fatty acids produce an 
inflammatory response predominantly through the activation of TLR4 signaling in 
hypothalamus: implications for the pathogenesis of obesity. J Neurosci. 29(2), 359-370.  
31 
 
39. Millar JS, Stone SJ, Tietge UJF, Tow, B, Billheimer, J, Wong, JS, Hamilton, RL, Farese, 
RV, Rader, DJ. (2006). Short-term overexpression of DGAT1 or DGAT2 increases 
hepatic triglyceride but not VLDL triglyceride or apoB production. J Lipid Res. 47(10), 
2297-2305. doi:10.1194/jlr.M600213-JLR200 
40. Munteanu MA, Nagy GA, Mircea PA. (2016). Current management of NAFLD. Clujul 
Med. 89(1):19-23. doi:10.15386/cjmed-539 
41. Musso G. (2012). Non-alcoholic fatty liver, adipose tissue, and the bone: a new 
triumvirate on the block. Endocrine. 42(2), 237-239. doi:10.1007/s12020-012-9748-2 
42. Naik A, Košir R, Rozman D. (2013). Genomic aspects of NAFLD pathogenesis. 
Genomics. 102(2), 84-95. 
43. O’Connell TM. (2013). The Complex Role of Branched Chain Amino Acids in Diabetes 
and Cancer. Metabolites, 3, 931-945; doi:10.3390/metabo3040931 
44. Ohlsson C, Mohan S, Sjogren K, Tivesten A, Isgaard J, Isaksson O. (2009). The role of 
liver-derived insulin-like growth factor-I. Endocr Rev. 30(5), 494–535. PubMed Central 
PMCID: PMC2759708. doi:10.1210/er.2009-0010 
45. O’Neill LA., Kaltschmidt C. (1997). NF-kB: a crucial transcription factor for glial and 
neuronal cell function. Trends Neurosci. 20(6), 252-258. 
46. Ong, K., Langkamp, M., Ranke, M., Whitehead, K., Hughes, I., Acerini, C., Dunger. D. 
(2009). Insulin-like growth factor I concentrations in infancy predict differential gains in 
body length and adiposity: the Cambridge Baby Growth Study. The American Journal of 
Clinical Nutrition, 90(1), 156–161, https://doi.org/10.3945/ajcn.2008.27408 
47. Patro-Golab, B, Zalewski, BM., Kouwenhoven, SM., Karas, J, Koletzko, B, Bernard van 
Goudoever, J, Szajewska, H. (2016). Protein Concentration in Milk Formula, Growth, 
32 
 
and Later Risk of Obesity: A Systematic Review. Journal of Nutrition. 146(3), 551-64. 
http://doi.org/ 10.3945/jn.115.223651. 
48. Pereira, PM., Vicente, AF. (2013). Meat nutritional composition and nutritive role in the 
human diet. Meat Sci. 93, 586–592. 
49. Rao, GN. (2002). Diet and Kidney Diseases in Rats. Toxicology Pathology, 30, 651–656. 
http://doi.org/10.1080/01926230290166733. 
50. Sanyal, AJ, Brunt, EM, Kleiner, DE, Kowdley, KV, Chalasani, N, Lavine, JE, Ratziu, V, 
McCullough, A. (2015). Endpoints and clinical trial design for nonalcoholic 
steatohepatitis. Hepatology, 54, 344–353 
51. Sauerwein, R, Mulder, J, Mulder, L, Lowe, B, Peshu, N, Demacker, P, van der Meer, J, 
Marsh K. (1997). Inflammatory mediators in children with protein-energy malnutrition. 
Am J Clin Nutr. 65(5), 1534-9. 
52. Song, S, Hooiveld, G, Li, M,  Zhao, F, Zhang, W,  Xu, X Muller, M, Li, C, Zhou, G.H. 
(2016). Distinct physiological, plasma amino acid and liver transcriptome responses to 
purified dietary beef, chicken, fish, and pork proteins in young rats. Molecular Nutrition 
& Food Research. 60. 1199–1205. https://doi.org/10.1002/mnfr.201500789. 
53. Strable, MS, Ntambi, JM. (2010). Genetic control of de novo lipogenesis: role in diet-
induced obesity. Crit Rev Biochem Mol Biol. 45(3), 199-214. 
doi:10.3109/10409231003667500 
54. Stenvinkel P, Ketteler M, Johnson R., Lindholm B, Pecoits-Filho R, Riella M., 
Heimbürger O, Cederholm T, Girndt M. (2005). IL-10, IL-6, and TNF-α: Central factors 
in the altered cytokine network of uremia—The good, the bad, and the ugly. Kidney 
International. 67(4), 1216-1233. https://doi.org/10.1111/j.1523-1755.2005.00200.x 
33 
 
55. Tamura S, Shimomura I. (2005). Contribution of adipose tissue and de novo lipogenesis 
to nonalcoholic fatty liver disease. J Clin Invest. 115(5), 1139-1142. 
doi:10.1172/JCI24930 
56. Tang M. (2018). Protein Intake during the First Two Years of Life and Its Association 
with Growth and Risk of Overweight.  International Journal of Environmental Research 
& Public Health. 15(8), E1742. http://doi.org/10.3390/ijerph15081742.  
57. Temple J, Cordero P, Li J, Nguyen V, Oben J. (2016). A Guide to Non-Alcoholic Fatty 
Liver Disease in Childhood and Adolescence. Int J Mol Sci. 17(6), 947. 
58. Trauner M, Claudel T, Fickert P, Moustafa T, Wagner M. (2010). Bile acids as regulators 
of hepatic lipid and glucose metabolism. Dig Dis. 28(1), 220-224. 
doi:10.1159/000282091 
59. Wan X, Wang S, Xu J, Zhuang L, Xing K, Zhang M. (2017). Dietary protein-induced 
hepatic IGF-1 secretion mediated by PPARγ activation. PLoS ONE, 12(3), e0173174. 
doi:10.1371/journal.pone.0173174 
60. Warren, D, Paker, I, Jaczynski, J, & Matak, KE. (2018). Nutritional Quality and Physical 
Characteristics of Soluble Proteins Recovered from Silver Carp. Journal of Food Science, 
83(7), 1970–1979. http://doi.org/10.1111/1750-3841.14170.  
61. Wibowo, S, Savant, V, Cherian, G, Savage, TF, Velazquez, G, & Torres, A. (2007). A 
Feeding Study to Assess Nutritional Quality and Safety of Surimi Wash Water Proteins 
Recovered by a Chitosan-Alginate Complex. Journal of Food Science, 72(3). 
http://doi.org/10.1111/j.1750-3841.2007.00291.x. 
34 
 
62. Yang H-Y, Tzeng Y-H, Chai C-Y, Hsieh A-T, Chen J-R, Chang L-S. (2011). Soy protein 
retards the progression of non-alcoholic steatohepatitis via improvement of insulin 
resistance and steatosis. Nutrition. 27, 943–8. 
63. Zhang, X., & Beynen, A. C. (1992). Increasing Intake of Soybean Protein or Casein, but 
Not Cod Meal, Reduces Nephrocalcinosis in Female Rats. The Journal of Nutrition, 
122(11), 2218–2225. http://doi.org/10.1093/jn/122.11.2218.  
64. Zutphen, T, Ciapaite, J, Bloks, V, Ackereley, C, Gerding, A, Jurdzinski, A. (2016). 
Malnutrition-Associated Liver Steatosis and ATP Depletion is caused by Peroxisomal 
and Mitochondrial Dysfunction. Journal of Hepatology, 65(6), 1198–1208. 
http://doi.org/10.1016/j.jhep.2016.05.046.  
  
35 
 
12. Figures and Tables 
 
 
Figure 1: Diagram of de novo lipogenesis, lipid storage, and lipid transport pathways. 
Adapted from Millar et al. (2013). Abbreviations: ACC, acetyl co-A carboxylase; ACL, ATP 
citrate synthase; ApoB, apolipoprotein B; ChREBP, carbohydrate response element bind 
protein; CPT-1, carnitine palmitoyltransferase 1; diacylglycerol O-acyltransferase 2; FAS, 
fatty acid synthase; FFA, free fatty acids; HSL, hormone sensitive lipase; LCE, long chain 
fatty acyl elongase; SCD, stearoyl-CoA desaturase; SREBP-1c; sterol regulatory element 
binding protein-1c; VLDL, very low-density lipoprotein. 
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Figure 2: Catabolism pathways for branched chain amino acids. Adapted from O’Connell et 
al. (2013).  Abbreviations: αKG, α-ketoglutarate; AcCoA, acetyl-CoA; Ala, alanine; ALT, 
alanine aminotransferase; ASCT2, ASC-type amino acid transporters; BCAAAT, branched 
chain amino acid aminotransferase; BCAADH, branched chain amino acid dehydrogenase; 
BCKA, branched chain ketoacid; Citr, citrate; CS, carnitine shuttle; DCC, dicarboxylate 
carrier; Glu, glutamate; GDH, glutamate dehydrogenase; GLS, glutaminase; Gln, glutamine; 
GLNS, glutamine synthetase; LAT1, Large neutral amino acid transporter; Lac, lactate; 
Leu, leucine; Mal, malate; NADP+; nicotinamide, adenine dinucleotide phosphate; 
NADPH, reduced form of nicotinamide, adenine dinucleotide phosphate; Pyr, pyruvate; 
TCC, tricarboxylate carrier. 
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Figure 3: Illustration of branched chain amino acids and IGF-1 role in the activation of 
mTORC1 and subsequent downstream pathways. Adapted from O’Connell et al., 2013. 
Abbreviations: Akt, Protein Kinase B; AMP, adenosine monophosphate; AMPK, adenosine 
monophosphate kinase; ATP, adenosine triphosphate; 4EBP1, eukaryotic translation 
initiation factor 4E binding protein 1; GLUT, glucose transport protein; IGF-1, insulin-like 
growth factor-1; IGF1R, IGF1 receptor; IR, insulin receptor; IRS-1, insulin receptor 
substrate 1; mTORC1, mammalian target of rapamycin complex 1; PI3K, 
phosphatidylinosotide 3-kinases; Rag GTPases, Rag guanine triphosphate hydrolysis 
enzymes; Rheb, Ras homolog enriched in brain;; S6K1, ribosomal protein S6 kinase; 
SREBP, sterol regulatory element-binding protein; TSC1/TSC2, complex of tuberous 
sclerosis proteins 1 & 2. 
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Chapter III 
Study Objectives and Hypotheses 
Study 1 
Previous research investigated in vitro nutritional quality of a water-soluble protein powder 
derived from silver carp. The results of this study indicated soluble proteins derived from silver 
carp are nutrient rich and have functional properties; however, bioavailability, protein quality 
and safety were not considered.  
Objective: To evaluate the protein quality of carp sarcoplasm protein (CSP) powder and the 
effects of low (10% kcal) protein diets on growth, body composition, renal markers, and bone 
health during growth and development. 
Hypothesis: Protein quality of CSP is expected to be comparable to popular commercially 
available milk proteins, casein and whey protein isolate. Collectively, these results are expected 
to contribute to fish sustainability by using an invasive fish species and by reducing the amount 
of protein required to be consumed for protein synthesis without negative affecting renal and 
bone health.   
Study 2 
Feeding growing rats diets consisting of 10% kcal protein as CSP showed no significant 
differences in nutrition quality compared to casein and whey protein and was determined to be 
safe. However, whey protein consumption enhanced adiposity. 
Objective: To assess the effect of low protein (10 % kcal) diets consisting of CSP compared to 
two common commercial protein powders (e.g. casein and whey) on lipid metabolism in liver 
and adipose tissue compared to a protein deficient diet.  
Hypothesis: CSP powder is expected to alter lipid metabolism resulting in reduced adiposity, 
adipose tissue lipolysis, and hepatic lipid accumulation compared to casein and whey protein. 
Study 3 
There were few alterations in lipid metabolism in rats fed low protein (10% kcal) diets derived 
from carp, casein, and whey protein. However, differences in amino acid profiles among 
different protein sources may have altered amino acid catabolism and insulin like growth factor 1 
(IGF-1) pathway activation. Additionally, greater hepatic lipid deposition was seen in rats fed a 
protein deficient diet.     
Objectives: To investigate distinct phenotypic and hepatic transcriptome responses due to low 
protein (10% kcal) diets consisting of CSP and milk proteins, casein and whey, in a growing 
animal model.  
Hypothesis: CSP consumption is expected to result in no difference in transcriptome responses 
compared to casein; whereas, increased branched chain amino acids in whey protein is expected 
up regulate IGF-1 secretion and related pathways. Further, protein deficient rats are expected to 
exhibit distinct transcript responses with upregulation of lipid synthesis and storage pathways 
compared to the protein fed diet groups. 
 
Overall Hypothesis: CSP is a high quality protein comparable to casein and whey protein. 
Lowering dietary protein content using CSP as the high quality protein is expected to be safe 
based on hepatic, renal, and bone health markers. Further, CSP may be preferable to whey 
protein for preventing weight gain due to adiposity. Based on these characteristics, CSP provides 
a sustainable alternative to current commercial protein powder.  
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Abstract 
Consisting of 25 – 30% of protein in carp, water-soluble sarcoplasmic proteins lost in wash 
water, have been recovered and freeze-dried into a protein-rich powder. Study objectives were to 
evaluate protein quality and safety of a silver carp sarcoplasm derived protein powder (CSP) 
compared to commercial protein supplements, casein and whey. In vivo protein quality 
assessment of CSP showed a lower (p<0.05) protein digestibility corrected amino acid score 
compared to the commercial protein sources. Despite greater (p<0.05) fecal amino acid excretion 
in casein fed rats, there were no significant differences in liver and muscle amino acid profiles. 
All low (10% kcal) protein diets supported growth with the normal range.  However, whey 
protein supplementation resulted in greater (p<0.05) adiposity. CSP, casein, or whey-fed rats 
showed no differences in major organ weights, renal damage biomarkers, or bone indices. 
Collectively, results indicated CSP was safe with protein quality comparable to casein.  
Keywords: Silver Carp, Sarcoplasm Protein, Protein Quality, Protein Safety, Amino Acid 
 
Practical Application 
As much as 40 percent of protein in fish can be lost due to sarcoplasmic protein solubilization in 
processing wash water. Silver carp sarcoplasm protein powder may have similar commercial 
potential as a sustainable and nutritious alternative to whey and casein proteins. This project 
aimed to verify the protein quality and safety of this economical protein source.      
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Introduction 
Current fishery resources are operating either close to optimal yield or at levels with elevated 
risk for fish stock depletion (FAO, 2016). In 2016, the Fishes and Aquaculture Organization 
reported global aquaculture growth declined by 3.3% meanwhile the human population continues 
to increase by 1.6%, annually with an expected global population of 10 billion by 2050. A 
solution for overcoming limitations of sustainable natural fish resources is through utilization of 
less desirable fish species and fish processing by-products. Silver carp (Hypophthalmichthys 
molitrix) was imported to the United States in the 1970s for use as filter feeders in aquaculture. 
Since their unintentional introduction into the wild, silver carp has become an invasive species 
resulting in negative impacts on the food chain in North American freshwater river systems 
(Chick, 2001). 
Carp is composed of 7.13% fat, consisting mainly of the health beneficial long-chain omega-
3 polyunsaturated fatty acids (n-3 PUFAs) (Ljubojević et al., 2017), and 16.69% protein, 
comprising all the essential amino acids required by adults and children (Skibniewska, 2013). 
Silver carp’s abundance and nutritional composition makes it a sustainable fish species. Due to 
its low commercial value as an edible fish in North American, carp may be processed into value-
added products such as surimi. In surimi manufacturing, myofibrilar (muscle) protein is 
concentrated through repeated washes (Arvanitoyannis & Kassaveti, 2008). During the washing 
steps in surimi manufacturing, the water-soluble sarcoplasmic protein comprised of 20 – 30 % of 
fish protein, are lost in wash water disposal (Okada, 1999).  
Previous research showed silver carp sarcoplasmic proteins in wash water can be recovered 
and freeze-dried into a protein-rich powder (Warren et al., 2018). However, before carp 
sarcoplasm protein (CSP) powder can be commercialized, the protein quality and safety of this 
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novel protein supplement needs to be evaluated. A study by Wibowo et al. (2007) compared 
sarcoplasm protein powder recovered from surimi wash water to casein and commercial protein 
meals. Protein recovered from surimi wash water was determined to be higher in protein quality 
than casein and commercial protein meals and considered safe based on an absence of significant 
changes in blood chemistry measurements after feeding 18% kcal protein to rats aged 40 days for 
20 days during the pubescent stage. Our study assessed the effects of lower (10% kcal) protein 
diets on anabolic development of immature (28 day old) rats for 28 days. Reduced protein was 
used to investigate whether lower protein content may reduce the risk of obesity and renal 
damage.  
An European multi-centered clinical study reported infants receiving a high protein formula 
resulted in higher kidney volume compared to infants receiving a low protein formula or 
breastfed infants. Higher kidney volume was attributed to increased renal workload indicated by 
greater serum urea/creatinine ratios (Escribano et al., 2011). Infant formulas often have higher 
protein content compared to human milk and this have been related to weight gain and obesity 
later-in-life (Tang, 2018). In a longitudinal study, infants fed lower amounts of protein, but of 
high-quality reduced risk of overweight or obesity (Koletzko et al., 2009). Marsh et al. (2016) 
predicted lower lifelong body mass index and lower incidence of obesity in individuals who 
received low protein infant formula. However, low protein intake during infancy effects on body 
composition has not been accessed raising safety concerns about adequate growth and maturation 
(Patro-Golab et al., 2016). 
 Therefore, the objectives of this study were to evaluate the protein quality of CSP and 
effects of a lower (10% kcal) protein diets on growth, body composition, renal markers, and bone 
health during growth and development. Weanling rats were used as a model for studying low 
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protein diets from different sources during growth. We hypothesize sarcoplasm protein-derived 
carp protein quality is comparable to popular commercially available milk proteins, casein and 
whey protein isolate (WPI) and in turn, can contribute to sustainability by reducing amount of 
protein consumed for protein synthesis.   
2 Materials and Methods  
2.1 Protein Powder Production  
Headed and gutted silver carp were purchased from FIN Inc. (Kentucky, USA) and 
shipped on ice through overnight mail to the West Virginia University Agricultural Sciences 
Building. Upon delivery, carp was unpacked from ice, immediately twice course ground in a 
meat grinder (Hobart, model # 4146 SS). Ground carp was portioned into vacuum-sealed bags 
and stored at -80°C until processing. CSP powder was recovered according to methods 
previously described by Warren and colleagues (2018). Briefly, thawed ground carp was mixed 
with 1:3 deionized and distilled water (ddH2O) and homogenized on ice for 10 min using a 
homogenizer (Omni International, model GLH, Kennesaw, GA USA) with a 45 mm probe 
(Omni International, model GLH, Kennesaw, GA USA). The homogenized paste was 
centrifuged (Sorvall, model 728211, Newtown, CT) at 10,000 × g for 15 min at 4°C and the 
sarcoplasmic protein supernatant (i.e. wash water) was collected and filtered through 
cheesecloth. Centrifugation was repeated on filtered supernatant, and additional supernatant was 
collected then filtered. Total supernatant (i.e. wash water) was freeze-dried into a powder in a 
freeze drier (VirTis, model #35L, SP Industries Inc., Warminster, PA USA). Purity of CSP was 
verified with proximate composition and sodium dodecyl sulfate–polyacrylamide gel 
electrophoresis (SDS-PAGE) in Warren et al. (2018). Proximate composition of the CSP powder 
was determined according to the Association of Official Analytical Chemists (AOAC) methods 
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(AOAC, 1995). Proximate composition and SDS-PAGE revealed CSP was 82% crude protein 
with the majority consisting of low molecular weight sarcoplasmic proteins (Warren et al., 
2018). 
2.2 Research and Development  
Amino acid analysis on the CSP powder was conducted at the University of Missouri-
Columbia according to the AOAC method 982.30 E (AOAC, 1995). Briefly, samples were 
hydrolyzed with 6 N hydrochloric acid at 110 °C for 24 hr. The samples were further oxidized by 
performic acid overnight at 0-5°C. Acid hydrolysis was repeated as described followed by a final 
alkaline hydrolysis with 4.2 N NaOH at 110°C for 22 hr. A Beckman amino acid analyzer 
(model 6300, Beckman Coulter, Fullerton, Calif., USA) was used to determine the amino acid 
profile of the hydrolyzed samples using sodium citrate buffers in step gradients with a cation 
exchange post-column ninhydrin derivation method. Amino acid composition of CSP, casein, 
and WPI is provided in Table 1. The CSP powder was vacuum-sealed and stored at -80 °C until 
used for rodent diet formulation.  
2.3 Diets 
 The American Institute of Nutrition-93G (AIN-93G), a standard purified diet that meets 
all the nutrient requirements for growing rats as defined by the National Research Council (1995) 
was used during the acclimation period. For treatment diets, AIN-93G diet was modified from 20 
% kcal protein to contain 10% kcal protein consisting of either CSP, casein or WPI. Diet 
ingredients and composition are provided in Table 1. All treatment diets were formulated to be 
isocaloric with the only difference being the protein source. All diets as well as casein and WPI 
were purchased from Envigo-Teklad (Madison, WI). 
2.4 Animal Feeding Study 
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The rodent feeding study was approved by the Animal Care and Use Committee (ACUC) 
at West Virginia University (WVU) (ACUC Protocol # 1603000861) and followed the 
guidelines set forth by the National Research Council for the Care of Laboratory Animals 
(2010). Immature (age 28 d) female Sprague-Dawley rats were purchased from Charles River 
(Worcester, MA). Upon arrival, rats were individually housed in metabolic cages throughout the 
study to collect urine and feces. Rats were maintained in room at 21°C with a 12h light/dark 
cycle.  
Rats were fed the purified AIN-93G diet during acclimation for 7 days. Following 
acclimation, rats were housed in metabolic cages and randomly assigned (n=8 rats/group) to one 
of four experimental diet groups: (1) AIN-93G with 10% kcal CSP for 4 weeks, (2) AIN-93G 
with 10% kcal casein for 4 weeks, (3) AIN-93G with 10% kcal WPI for 4 weeks or, (4) AIN-
93G with 10% kcal casein for 2 weeks followed by protein free diet for the remaining 2 weeks to 
assess endogenous protein loss. Rats were fed 16.0 ± 0.2 g of their assigned diet daily throughout 
the study duration.  
Food intake was recorded then replaced with fresh diet daily. Methods as described by 
Gigliotti et al. (2008) were used to calculate feed consumption. Rats were provided deionized, 
distilled water ad libitum. Intake of ddH2O was measured weekly by recording pre- and post-
bottle weights and amount spilled. Urinary and fecal samples were collected weekly. A screen in 
the metabolism cages separated feces and urine. Ascorbic acid (0.1%) was added to the urine 
collection tube as a preservative with 1 ml of mineral oil added to prevent evaporation. Body 
weight was recorded weekly. Following 4 weeks of feeding, animals were fasted for 12 h and 
euthanized by carbon dioxide inhalation according to the WVU ACUC approved protocol.  
2.5 Protein Quality Measurements 
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Protein quality measurements included: true digestibility (D), true biological value (BV), 
net protein utilization (NPU), amino acid score (AAS), protein digestion corrected for amino 
acid score (PDCAAS) and relative protein efficiency ratio (PER). Relative PER values were 
adjusted to the standardized 2.5 value for the casein reference. Protein quality measurements 
were calculated according to the FAO (1990) where I is nitrogen intake, FN is fecal nitrogen 
excreted, EFN is endogenous fecal nitrogen, UN is urinary nitrogen excreted, and EUN is 
endogenous urinary nitrogen excreted using the formulas below: 
 
True Digestibility (D) = [I – (FN – EFN)) / I] 
True Biological Value (BV) = [I – (FN – EFN) – (UN – EUN]/ (I – (FN – EFN)] 
Net Protein Utilization (NPU) = [I – (FN – EFN) - (UN – EUN)]/ I 
Amino Acid Score (AAS) = (amount of limiting amino acid in the test protein /measured 
amount of limiting amino acid in reference protein) 
Protein Digestibility Corrected for Amino Acid Score (PDCAAS) = (AAS) x D 
Relative Protein Efficiency Ratio (PER) = Body Weight / (I*6.25) 
 
Collected urine samples were centrifuged at 1500 x g for 10 min at 4oC then aliquoted 
into fresh tubes and stored at -20°C until assayed for nitrogen content. Fecal samples were 
freeze-dried for 48 h then stored at -20°C until assayed for crude nitrogen content. Nitrogen 
measurements were obtained using the Kjeldahl method (AOAC, 1995).  
2.6 Biological Sample Amino Acid Analysis 
Amino acid profiling was performed on hepatic tissue, gastrocnemius muscle, and fecal 
samples collected during the final week. Biological samples were freeze-dried (VirTis, model 
#35L, SP Industries Inc., Warminster, PA USA). After drying, 15 mg of each biological sample 
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was hydrolyzed with 6N HCl in evacuated sealed tubes at 99°C for 24 h. Amino acids from 
hydrolyzed biological samples were isolated and derivatized using the Easy-Fast Amino Acid 
Sample Testing kit (Phenomenex, Torrance, CA). Amino acids were quantified using a gas 
chromatograph (GC) (6890N, Agilent Technologies, Santa Clara, CA, USA) coupled to a mass 
spectrometry (MS) detector (5975B, Agilent Technologies, Santa Clara, CA, USA) equipped 
with an autosampler (7683B, Agilent Technologies, Santa Clara, CA, USA). 
Hepatic, gastrocnemius muscle, and fecal samples were dried and sent to the University 
of Missouri-Columbia for cysteine, methionine, and tryptophan verification. Cysteine and 
methionine analysis were conducted according to the AOAC official method 994.12 with 
performic acid oxidation (AOAC, 1995). While tryptophan analysis was conducted according to 
the AOAC official method 988.15 with alkaline hydrolysis (AOAC, 1995). 
2.7 Organ Weights and Renal Function Measurements 
Immediately following euthanasia by carbon dioxide inhalation, kidneys and other major 
organs (i.e. brain, heart, liver, lungs) as well as spleen and thymus were dissected, trimmed, 
blotted dry, and weighed as indicators of toxicity. The adrenals were weighed as indicators of 
chronic stress. Retroperitoneal and gonadal fat pads were also excised and weighed. Collected 
organs and adipose tissue were flash frozen in liquid nitrogen and stored at -80°C.  
Blood was collected by cardiac puncture and centrifuged at 1500 × g at 4°C for 10 min. 
Serum was collected and stored at -80°C until analyzed. Renal function was assessed by 
measuring serum blood urea nitrogen (BUN), creatinine, total protein, albumin, calcium (Ca) and 
phosphorus (P) by enzymatic colorimetric assays using a commercially available Vet- 16 rotor. 
Absorbance was measured at 595 nm by Hemagen Analyst automated spectrophotometer 
(Hemagen Diagnostics Inc., Columbia, MD).   
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Determination of urinary calcium (Ca) excretion and kidney Ca content was conducted 
according to methods described by Gigliotti and colleagues (2010). Briefly, right kidneys were 
dried overnight in an oven then ashed in a muffle furnace (Lindberg 515A2, Watertown, WI) for 
24 h at 550°C. Ashed kidneys were dissolved in 70% nitric acid (1 mL). Acidified samples were 
diluted with 5 mL of ddH2O, filtered through Whatman no. 1 paper then diluted (1:50 v/v) to 
volume with ddH2O. Urine was diluted (1:10 v/v) to volume with ddH2O. Kidney and urinary Ca 
content was measured using inductively coupled plasma optical emission spectroscopy (model 
P400, Perkin-Elmer, Shelton, CN).  
2.8 Bone Measurements  
Left and right femurs were dissected, defleshed, wrapped in saline soaked gauze, and 
stored at -20°C until assayed. Bone morphometry measurements of medial lateral width, anterior 
posterior width, and length were determined using a Vernier caliper (Bel-Art Products, 
Pequannock, NJ). Length was measured from the medial condyle to greater trochanter. Bones 
were dried at 110°C for 24 h then weighed using an analytical balance (Mettler Toledo, 
Columbus, OH). Morphometry measurements were averaged for bone pairs (i.e. right and left) 
after no bilateral differences were determined using paired t-test with significance level set at 
p<0.05. 
Bone strength indices were assessed using a TA.XT2i Texture Analyzer (Texture 
Technologis Corp, NY) equipped with a three-point bending apparatus. The femora were placed 
on supports (1 mm width at tip for femur) and force applied on the medial surface of the bones 
by lowering a centrally placed blade (1 mm width) at a constant crosshead speed (0.1 mm/sec) 
until the bone was broken. The load cell was 50 kg. The load-deflection data were collected by 
PC interfaced with the TA.XT2i Texture Analyzer. Sample test distance was set at 10 mm with a 
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signal collection rate of 100 points per sec. A force-displacement curve generated from the 
biomechanical test was used to determine bone strength measurements. Peak force was measured 
as the highest load obtained before bone fracture occurs. Ultimate stiffness was measured as the 
slope of the curve responding to bone stiffness (Skinner et al., 2019). Ultimate bending stress is a 
normalized calculated force that take into account the size of the bone while Young’s Modulus is 
a normalized calculated bone stiffness taking into account bone size (Skinner et al., 2019). 
Total mineral content was determined as described by Skinner et al. (2019). Briefly, 
bones were ashed in a muffle furnace (Lindberg 515A2, Watertown, WI) for 24 h at 600°C and 
then weighing ash. To determine bone Ca and P content, ashed femurs were dissolved in 70% 
nitric acid (1 mL). Acidified samples were diluted with 5 mL of ddH2O, gravity filtered through 
Whatman no. 1 paper then diluted (1:50 v/v) to volume with ddH2O. Bone Ca and phosphorus 
concentrations were measured using inductively coupled plasma optical emission spectroscopy 
(model P400, Perkin-Elmer, Shelton, CN).  
2.9 Statistical Analysis 
A completely randomized design was used in the animal feeding study with n = 8 rats per 
experimental diet group. Results are expressed as mean ± standard error of the mean. One-way 
ANOVA was used to determine differences among diet treatment groups. Post-hoc multiple 
comparison tests were performed using Tukey’s test with treatment differences considered 
significant at p<0.05 and tendency at p=0.08. All statistical analyses were performed using JMP 
12.2 statistical software package (SAS Institute, Cary, NC).  
3 Results and Discussion 
3.1 Protein Quality Assessments 
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 Lowering the protein content of infant formula has been suggested to reduce risk for 
developing overweight and obesity in children (Koletzko et al., 2009). When the quantity of 
dietary protein is reduced protein quality and digestibility becomes more important for sustaining 
growth. In our study, protein true digestibility showed no significant differences between CSP, 
casein, and WPI. On the other hand, protein quality measurements of biological value (BV) and 
net protein utilization (NPU) were higher (p<0.05) for CSP compared to WPI, but not casein 
(Table 2). These measurements indicate rats consuming CSP and casein retained more nitrogen 
compared to rats consuming WPI. This may be the result of casein being a ‘slow’ digested 
protein due to coagulation in the stomach providing a sustained release of amino acids into the 
blood for better nitrogen retention and utilization by the body (Boirie et al., 1997). Based on 
comparable nitrogen retention to casein, CSP may also be a ‘slow’ protein. 
PDCAAS is used to calculate protein % Daily Value on the Nutrition Facts Label and is 
the routine method of estimating protein quality (Schaafsma, 2000; FOA, 1990). PDCAAS for 
CSP was lower (p< 0.05) than both milk proteins, with casein having the highest PDCAAS 
(p<0.05) (Table 2). Based on dietary amino acid analysis (Table 1), Phenylalanine + Tyrosine 
was the limiting essential amino acid in CSP at 64.74 ± 0.65 mg/g protein, resulting in an amino 
acid score of 0.61 and subsequently the lowest (p < 0.05) PDCAAS (0.57 ± 0.01). EAA content 
was higher for whey compared to casein, with the exception of valine and histidine. PDCAAS 
for WPI (0.63 ± 0.01) using histidine as the limiting amino acid was low compared to the 
reported value of 1 for WPI (Hoffman & Falvo, 2004). However, PDCAAS does not take into 
consideration the individual amino acids are digested with different efficiencies (Mathai et al., 
2017). PDCAAS was adopted as a routine assay for protein quality evaluation because it is rapid; 
however, it often shows discrepancies compared to PER (Schaafsma, 2000). The protein quality 
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calculation used in the development of infant formulas is PER since this calculation measures a 
protein’s ability to support anabolic functions (Gropper, Smith, & Groff, 2005). In the current 
study, there were no significant differences in relative and adjusted PER values among CSP, 
casein, and WPI diet groups (Table 2). Similarly, Gigliotti and colleagues (2008) measured 
protein quality of protein recovered from krill, another aquatic protein source, reported no 
significant difference in PER compared to casein protein. WPI was not included in the Gigliotti 
et al. (2008) study. Wibowo et al. (2007) reported a greater (p<0.05) PER for water-soluble 
protein extracted from surimi wash water when compared to casein after correcting for lower 
methionine content. Collectively, the protein quality measurements suggest CSP was comparable 
to casein and WPI for digestibility, supporting growth, and most protein quality measurements.  
3.2 Fecal and Tissue Amino Acid Profiles  
 Of the protein sources, casein-fed rats had the highest (p<0.05) fecal excretion of the 
essential amino acid valine, as well as non-essential amino acids: alanine, serine, and glutamic 
acid (Table 3). This may be attributed to higher content of these amino acids in the casein diet 
with the exception of alanine. This may be because alanine is also used in the urea cycle and 
excreted as urinary urea. In a study using growing pigs, animals fed a low protein diet reduced 
nitrogen loss by restricting portal vein transport of alanine to the liver since alanine is a primary 
nitrogen source for urea production (Wu et al., 2018). In the present study, liver content of 
ornithine, an intermediate in the urea cycle, showed no significant differences among rats 
consuming casein, CSP, and WPI.  
 Rats fed a protein-free diet for 2 weeks significantly lowered liver content of essential 
amino acids: leucine, methionine + cysteine, phenylalanine + tyrosine, lysine, and histidine 
compared to rats fed CSP and casein. Lower hepatic essential amino acid content may be due to 
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their use for synthesis of non-essential amino acids since almost all essential amino acid 
catabolic enzymes are found in the liver (Rao, 2002). Of the non-essential amino acids, only liver 
tyrosine content was lower in rats consuming the protein-free compared to CSP diet; whereas, 
liver content of alanine, proline, aspartic acid, and tyrosine was lower in in rats consuming the 
protein-free compared to casein diet (Table 3). However, feeding rats low protein diets as either 
CSP, casein, or WPI showed no significant differences in amino acid profile in the liver (Table 
3). Collectively, fecal and tissue amino acid profiling results indicated among the different 
protein sources, casein consumption resulted in the lowest nitrogen loss and highest hepatic 
amino acid retention.   
Further, there were no significant differences in muscle weights (Table 4) or 
gastrocnemius muscle amino acid profile (Table 3) among rat fed CSP, casein, and WPI. 
Interestingly, rats fed a protein-free diet for 2 weeks also showed no significant differences in 
gastrocnemius muscle amino acid profile despite lower gastrocnemius muscle weight compared 
to rats fed low (10% kcal) protein diet. This may be due to the ability of numerous transaminases 
and deaminase in the liver to synthesize different amino acids to adjust amino acid imbalances in 
the blood and peripheral tissues such as the muscles (Ritskes-Hoitinga et al., 1989).  
3.3 Growth  
Protein energy malnutrition has been characterized by stunted growth and fatty liver 
(Zutphen et al., 2016; Waterlow, 1992). Growth rate can be influenced by the amount of protein 
intake and the type of amino acid. Further, high quality proteins can contribute to sustainability 
by reducing amount of protein consumed for protein synthesis. Lowering protein content of 
infant formula has been suggested to have minimal effects on short term growth outcomes 
(Timby et al., 2014). Supplementation of CSP and casein promoted comparable growth indicated 
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by no significant differences in body weights throughout the 4 weeks study. On the other hand, 
rats fed WPI had the highest (p<0.05) body weight starting at 2 weeks (Figure 1). Rats 
consuming WPI showed no significant differences in gastrocnemius and soleus muscles weights 
compared to rats consuming CSP and casein (Table 4). There were no significant differences in 
retroperitoneal adipose among protein-fed groups. However, rats fed WPI had significantly 
higher gonadal adipose weight compared to rats fed CSP (Table 4). Higher gonadal adipose 
weight in rats fed WPI may be due to greater feed efficiency than rats fed CSP (Table 2). 
Additionally, dietary amino acid analysis showed WPI contained more dietary leucine and 
isoleucine (Table 1). Branch chain amino acids (BCAA): leucine, isoleucine and valine not only 
act as substrates for protein synthesis and synthesis of nitrogenous compounds, but as signaling 
molecules regulating glucose and lipid metabolism (Nie et al., 2018). Melnik (2012) reported 
BCAAs are physiological stimuli of insulin and insulin like growth factor-1 (IGF-1) which 
stimulates adipogenesis. Collectively, results suggest high consumption of BCAAs may promote 
adiposity.    
In our study, feeding a low (10% kcal) protein diets as CSP, casein or WPI supported rat 
growth within the normal range according to body growth chart for female Sprague-Dawley 
provided by the animal vendor (Charles River, Worcester, MA). Additionally, measurement of 
major organ weights as well as spleen and thymus as an indicator of toxicity showed no 
significant differences for rats fed CSP, casein, and WPI; whereas, feeding a protein-free diet for 
2 weeks resulted in lower weight of spleen, thymus, and all major organs except for the brain 
(Table 4). Koletzko et al. (2009) reported infants fed formulas with lower amounts of higher 
quality protein resulted in lower body weight with no effects on infant growth. The authors 
suggested consumption of high-quality proteins at lower levels may reduce risk of obesity later 
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in life. Based on our study results, CSP supported comparable growth to casein while WPI 
increased gonadal adipose compare to CSP. Therefore, CSP may be suitable for supporting 
growth of lean body mass in lower protein infant formulas. 
3.4 Evaluation of Kidney Health  
 Another consideration for decreasing protein content in infant formulas is based on 
reports of greater kidney size and workload in infants receiving a high versus low protein 
formula (Escribano et al., 2011). In our study, there were no significant differences in kidney 
weights among protein-fed groups. Rats fed a protein-free diet for 2 weeks had lower kidney 
weights (Table 4), but this was no longer significant after correcting for their smaller body size 
(Supplemental Table 1). Diet is a major factor influencing urinary Ca excretion which promotes 
hypercalciuria and can lead to nephrocalcinosis (Khan, 2010). A randomized study including 
1,090 healthy term infants from five different countries reported hypercalciuria prevalence in 
16.8% of infants fed a high protein formula (2.05-3.20 g/100mL) compared to 4.9% of infants 
fed a low protein formula (1.25-1.60 g/100 mL) for 3 months (Ferre et al., 2017).  
Wibowo et al. (2007) reported 18% kcal sarcoplasm protein powder was safe based on 
serum measurements of kidney function using male rats. However, diet-induced nephrocalcinosis 
is a more common occurrence in female rats (Rao, 2002). The transition of nephrocalcinosis to 
nephrolithiasis has been implicated in nephropathy and subsequent renal failure in rats (Jara et 
al., 2004). Zhang and Beynan (1992) reported feeding a 18% kcal protein diet resulted in greater 
renal Ca deposition in rats fed a casein diet compared to cod meal. Gigliotti and colleagues 
(2010) reported greater kidney weights and renal Ca deposition indicative of nephrocalcinosis in 
female rats fed 10% kcal as casein compared to krill protein concentrate. In the present study, 
despite higher Ca content in casein and CSP diet compared to WPI diet (Table 1) there were no 
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significant differences in urinary Ca excretion among diet groups (Table 5). There were also no 
significant differences in histological evidence of Ca deposits in renal intratubular or interstitial 
parenchyma (data not shown) or kidney total Ca content among protein-fed rats (Table 5). 
Further, there were no significant differences in any serum markers of renal function among rats 
fed CSP, casein or WPI (Table 5). However, another safety concern is ensuring adequate protein 
during the growth stage for bone health.  
3.5 Evaluation of Bone Health 
Kerstetter and colleagues (2003) reported low dietary protein intake correlated with 
reduced bone density and increased rates of bone loss. Reduced bone density and structure 
during growth and development increases risk of osteoporosis in adulthood (Gordon et al., 2017). 
In the current study, the importance of adequate protein for bone was indicated by reduced 
(p<0.05) femur longitudinal growth, bone size, and lower total bone mineral content (BMC) in 
rats fed a protein-free diet (Table 5). Among rats fed different sources of protein, there were no 
significant differences (p<0.05) in femoral longitudinal growth, bone size, total BMC, or Ca and 
P content (Table 5). Similarly, Gigliotti and colleagues (2010) showed no significant differences 
in femoral total bone mineral content, Ca, P between rats fed 10% kcal krill protein concentrate 
compared to casein.    
Chronic low protein diets have been associated with reduced bone mineral density and 
increased risk of fracture (Kerstetter et al., 2003). In our study there were no significant 
differences among dietary protein groups in any femur biomechanical strength measurements 
(Table 5). Similarly, rats fed 10% krill protein concentrate and casein showed no differences in 
bone strength (Gigliotti et al., 2010). In our study, absence of adverse bone effects in the protein-
free group may be because two weeks on a protein-free diet may not be a sufficient duration to 
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reduce bone strength. There also may have been a bone protective effect with adequate mineral 
intake provided in the diets. Ca and P are critical for formation of hydroxyapatite which provide 
mechanical resistance of the organic bone matrix (Bonjour, 2011). Fournier et al., (2014) found 
growing Sprague-Dawley female rats consuming a Ca (0.2%) and P (0.16%) diet for eight weeks 
attenuated the low protein (5% casein) diet-related reduction in bone mass and strength. 
Collectively, the bone results in the current study showed CSP was as safe as casein and WPI.  
Conclusion 
The study results indicated protein quality of CSP powder was comparable to standard 
reference and popular commercially available, casein and WPI. There were no significant 
differences in liver or muscle amino acid profile among protein protein-fed rats despite higher 
fecal amino acid excretion in casein-fed rats due to body’s compensatory amino acid balance 
mechanisms. Importantly, feeding low (10% kcal) protein diets supported rat growth within the 
normal range. Additionally, CSP or casein may be better sources for lowering the protein in 
infant formula to prevent obesity since WPI showed greater gonadal adipose weight. Safety was 
indicated by rats fed CSP, casein or WPI having higher major organ weights, lymphatic tissue 
weights compared to rats fed a protein-free diet. There were no significant differences in renal 
function biomarkers or bone indices. Collectively, the animal study results indicated CSP derived 
from fish processing waste water provides a high quality that may contribute to sustainability by 
reducing amount of protein consumed to support adequate body and organ growth. Therefore, 
CSP merits further investigation in human studies as a novel sustainable protein source for 
potential commercialization. 
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Table 1: Amino acid and nutritional composition of different protein sources and ingredient 
formulation of experimental protein diets.  
  CSP  Casein* WPI* No-Protein* 
Component (%)     
Moisture 6.86 11.1 4.7 - 
Protein 75.64 85.5 93.9 - 
Lipid 2.77 0.6 0.3 - 
Ash 15.8 2.8 1.5 - 
Essential Amino Acid (mg/g protein)    
Valine 47.21 ± 0.18 70 56 - 
Leucine 62.96 ± 0.26 94 143 - 
Isoleucine 38.23 ± 0.14 58 63 - 
Threonine 32.13 ± 0.21 44 53 - 
Methionine + Cysteine 26.35 ± 0.27 31 64 - 
Phenylalanine + Tyrosine 64.74 ± 0.65 105 80 - 
Lysine 74.46 ± 0.44 82 112 - 
Histidine 43.62 ± 0.24 29 20 - 
Tryptophan 11.49 ± 0.16 12 24 - 
Arginine 37.72 ± 0.21 39 30 - 
Total Essential Amino Acid 438.91 506 563 - 
Non-essential amino acids (mg/g protein)    
Alanine 48.86 ± 0.22 32 57 - 
Glycine 51.07 ± 0.27 19 18 - 
Serine 28.17 ± 0.28 56 45 - 
Proline 23.31 ± 1.05 84 45 - 
Aspartic Acid 81.58 ± 0.42 71 125 - 
Glutamic Acid 83.74 ± 0.48 229 176 - 
Tyrosine 23.21 ± 0.18 54 42 - 
Cysteine 9.88 ± 0.03 4 40 - 
Taurine 25.98 ± 0.45 ND ND - 
Total NEAA 375.8 549 548 - 
Minerals (mg/g)     
Calcium 295** 200 76 - 
Phosphorus 2188** 8000 ND - 
Sodium 818** <100 560 - 
Magnesium 188** <200 ND - 
Selected Nutrient Information*    
Protein (%) 10 10 10.3 0 
Carbohydrate (%) 66.9 67.8 68.1 78.1 
Fat (%) 7 7.1 7 7 
Energy (kcal/g) 3.7 3.8 3.8 3.8 
Ingredient (g/kg)*     
Whey Protein Isolate - - 111 - 
Casein - 115 - - 
Carp Protein  131.5 - - - 
Corn Starch 482.236 492.036 495.286 605.986 
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Maltodextrin 132 132 132 132 
Sucrose 100 100 100 100 
Soybean Oil 66.5 70 70 70 
Cellulose 50 50 50 50 
Mineral Mix 13.4 13.4 13.4 13.4 
Calcium Phosphate 0.75 9.8 13.2 13.4 
Calcium Carbonate 11.1 5.25 2.6 2.7 
Vitamin Mix 10 10 10 10 
Choline Bitartate 2.5 2.5 2.5 2.5 
TBHQ*** 0.014 0.014 0.014 0.014 
ND; no data 
*Received from Envigo-Teklad (Madison, WI) 
**Based on Warren et al., 2018. 
***Tertiary butylhydroquinone 
Values are mean ± SEM with n = 3 samples/group.
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Table 2: Protein quality and growth of female rats fed 10% protein diets consisting of casein, whey protein isolate, carp sarcoplasmic 
protein, or 2 weeks on 10% casein diet followed by a no-protein diet. 
 CSP Casein WPI No-Protein 
Protein Quality Measure     
True Digestibility (%) 94.43 ± 1.15 91.33 ± 2.37 94.03 ± 1.06 - 
Biological Value 0.75 ± 0.04a 0.73 ± 0.02a 0.61 ± 0.04b - 
Net Protein Utilization (%) 71.32 ± 3.99a 66.78 ± 1.88a 52.99 ± 4.83b - 
Amino Acid Score 0.61* 1 0.68* - 
PDCAAS 0.57 ± 0.01c 0.91 ± 0.02a 0.63 ± 0.01b - 
Relative Protein Efficiency Ratio (g body wt/g protein) 1.66 ± 0.06 1.87 ± 0.08 1.81 ± 0.11 - 
Adjusted Protein Efficiency Ratio  2.22 2.5 2.43 - 
Fecal Nitrogen Excretion (mg/day) 20.57 ± 2.50 ab 30.33 ± 3.92 a 30.36 ± 6.07 a 8.41 ± 0.98 b 
Urinary Nitrogen Excretion (mg/day) 60.81 ± 7.03 b 58.36 ± 3.97 b 91.10 ± 8.37 a 10.61 ± 1.72 c 
Growth Parameters     
Total diet intake (g/4 weeks) 449.98 ± 3.13a 441.65 ± 6.99a 460.49 ± 1.79a 380.59 ± 11.52b 
Feed efficiency (g body wt/g diet intake) 0.16 ± 0.004b 0.19 ± 0.009ab 0.20 ± 0.006a 0.04 ± 0.007c 
Final Body weight (g) 202.85 ± 3.33b 207.26 ± 2.89b 219.66 ± 2.66a 141.70 ± 2.98c 
Total body weight gain (g/4 week) 73.93 ± 1.71b 82.68 ± 4.04ab 93.69 ± 3.11a 15.82 ± 2.75c 
*Phenylalanine + Tyrosine is the first limiting amino acid of CSP; Histidine is the first limiting amino acid for WPI 
True Digestibility (D)  = [I – (FN – EFN)] / I]; True Biological Value (BV) = [I – (FN – EFN) – (UN – EUN)]/ [I – (FN – EFN)]; Net 
Protein Utilization (NPU)  = [I – (FN – EFN) - (UN – EUN)]/ I; Amino Acid Score = (amount of limiting amino acid in the test 
protein /measured amount of limiting amino acid in reference protein); Protein Digestion Corrected for Amino Acid Score (PDCAAS) 
= Amino Acid Score x True Digestibility; Relative Protein Efficiency Ratio (PER)  = Body Weight / (I*6.25); Corrected PER = PER × 
1.34. 
Values are mean ± SEM of n = 8 rats/group. Different superscript letters a and b within the same row indicate significant difference at 
p<0.05 by One-way ANOVA followed by Tukey’s test  
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Table 3. Fecal, hepatic, and skeletal muscle amino acid profile of female rats fed 10% protein diets consisting of carp sarcoplasmic 
protein, casein, whey protein isolate, or 2 weeks on 10% casein diet followed by a no-protein diet.  
Feces Liver Gastrocnemius Muscle 
Amino acids 
(mg/g sample) 
CSP Casein WPI No-
Protein 
CSP Casein WPI No-
Protei
n 
CSP Casein WPI No-
Protein 
Essential amino 
acids 
            
Valine 0.40 ± 
0.03b 
0.56 ± 
0.03a 
0.39 ± 
0.03b 
0.32 ± 
0.02b 
3.03 ± 
0.14 
3.16 ± 
0.13 
2.67 ± 
0.21 
2.37 ± 
0.30 
2.60 ± 
0.29 
2.67 ± 
0.29 
2.82 ± 
0.28 
2.57 ± 
0.23 
Leucine 0.55 ± 
0.05ab 
0.7 ± 
0.01a 
0.58 ± 
0.04ab 
0.47 ± 
0.03b 
6.95 ± 
0.28a 
7.22 ± 
0.26a 
6.05 ± 
0.49ab 
5.27 ± 
0.56b 
7.26 ± 
0.42 
7.51 ± 
0.27 
7.94 ± 
0.18 
7.50 ± 
0.26 
Isoleucine ND ND ND ND 1.79 ± 
0.08 
1.87 ± 
0.08 
1.66 ± 
0.13 
1.52 ± 
0.20 
2.08 ± 
0.24 
2.32 ± 
0.30 
2.28 ± 
0.29 
2.20 ± 
0.23 
Threonine 0.39 ± 
0.05ab 
0.46 ± 
0.3a 
0.42 ± 
0.03ab 
0.32 ± 
0.02b 
3.04 ± 
0.15 
3.26 ± 
0.12 
2.78 ± 
0.26 
2.41 ± 
0.31 
3.30 ± 
0.40 
3.03 ± 
0.31 
3.38 ± 
0.35 
3.02 ± 
0.31 
Methionine + 
Cysteine 
0.45 ± 
0.04 
0.50 ± 
0.04 
0.44 ± 
0.03 
0.45 ± 
0.04 
2.14 ± 
0.06ab 
2.22 ± 
0.09a 
1.94 ± 
0.17ab 
1.59 ± 
0.22b 
3.28 ± 
0.06 
3.00 ± 
0.22 
3.04 ± 
0.18 
2.93 ± 
0.18 
Phenylalanine + 
Tyrosine 
0.25 ± 
0.02 
0.28 ± 
0.02 
0.25 ± 
0.02 
0.22 ± 
0.02 
7.56 ± 
0.20a 
7.88 ± 
0.17a 
6.58 ± 
0.42ab 
5.35 ± 
0.46b 
8.20 ± 
0.53 
7.10 ± 
1.11 
8.23 ± 
1.00 
5.36 ± 
1.09 
Lysine 0.41 ± 
0.19 
0.54 ± 
0.15 
0.16 ± 
0.07 
0.19 ± 
0.12 
4.74 ± 
0.44a 
5.28 ± 
0.29a 
3.99 ± 
0.43ab 
3.03 ± 
0.49b 
6.23 ± 
0.93 
6.75 ± 
0.84 
7.27 ± 
0.87 
6.33 ± 
0.70 
Histidine 0.25 ± 
0.01 ab 
0.31 ± 
0.02a 
0.24 ± 
0.01ab 
0.22 ± 
0.01b 
3.45 ± 
0.25a 
3.47 ± 
0.19a 
2.79 ± 
0.27ab 
2.28 ± 
0.33b 
3.66 ± 
0.31 
4.59 ± 
0.40 
4.18 ± 
0.31 
3.96 ± 
0.39 
Tryptophan 0.05 ± 
0.01 
0.06 ± 
0.01 
0.04 ± 
0.01 
0.05 ± 
0.01 
0.31 ± 
0.06b 
0.55 ± 
0.09ab 
0.42 ± 
0.04ab 
0.66 ± 
0.04b 
0.95 ± 
0.03 
0.91 ± 
0.06 
0.94 ± 
0.02 
0.92 ± 
0.01 
Non-essential 
amino acids 
            
Alanine 0.47 ± 
0.05b 
0.64 ± 
0.04a 
0.46 ± 
0.04b 
0.41 ± 
0.02b 
4.67 ± 
0.19ab 
4.92 ± 
0.17a 
4.06 ± 
0.34ab 
3.65 ± 
0.40b 
5.33 ± 
0.49 
5.40 ± 
0.38 
5.53 ± 
0.49 
5.12 ± 
0.29 
Glycine 0.37 ± 
0.03 
0.45 ± 
0.013 
0.41 ± 
0.017 
0.38 ± 
0.037 
3.68 ± 
0.10 
3.95 ± 
0.08 
3.24 ± 
0.28 
3.07 ± 
0.37 
5.50 ± 
0.33 
6.69 ± 
0.86 
5.49 ± 
0.58 
5.51 ± 
0.39 
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Serine 0.44 ± 
0.06b 
0.89 ± 
0.04a 
0.47 ± 
0.04b 
0.41 ± 
0.03b 
3.61 ± 
0.17 
3.85 ± 
0.13 
3.28 ± 
0.30 
2.91 ± 
0.35 
4.85 ± 
0.36 
5.56 ± 
0.73 
4.79 ± 
0.28 
4.87 ± 
0.36 
Proline 0.49 ± 
0.05ab 
0.61 ± 
0.02a 
0.50 ± 
0.03ab 
0.42 ± 
0.02b 
4.45 ± 
0.19ab 
4.91 ± 
0.12a 
4.09 ± 
0.35ab 
3.66 ± 
0.48b 
4.78 ± 
0.60 
4.95 ± 
0.58 
5.10 ± 
0.78 
4.46 ± 
0.49 
Aspartic acid 0.87 ± 
0.13 
0.97 ± 
0.11 
0.80 ± 
0.09 
0.67 ± 
0.09 
7.45 ± 
0.32ab 
7.93 ± 
0.23a 
6.54 ± 
0.60ab 
5.73 ± 
0.32b 
6.76 ± 
1.57 
6.03 ± 
1.61 
6.96 ± 
1.44 
5.95 ± 
1.30 
Glutamic acid 0.89 ± 
0.13b 
1.56 ± 
0.20a 
0.90 ± 
0.09b 
0.81 ± 
0.13b 
7.45 ± 
0.34 
7.85 ± 
0.24 
6.71 ± 
0.56 
6.13 ± 
0.70 
8.82 ± 
1.73 
8.49 ± 
1.84 
8.96 ± 
1.75 
8.27 ± 
1.55 
Tyrosine 0.25 ± 
0.02 
0.28 ± 
0.02 
0.25 ± 
0.02 
0.22 ± 
0.02 
2.93 ± 
0.10a 
3.09 ± 
0.08a 
2.57 ± 
0.23ab 
2.03 ± 
0.27b 
4.01 ± 
0.33 
4.34 ± 
0.26 
4.42 ± 
0.36 
4.19 ± 
0.32 
             
Cysteine 1.04 ± 
0.07 
1.11 ± 
0.06 
0.99 ± 
0.08 
0.75 ± 
0.09 
1.04 ± 
0.07ab 
1.11 ± 
0.06a 
0.99 ± 
0.08ab 
0.75 ± 
0.09b 
0.91 ± 
0.02 
0.89 ± 
0.04 
0.88 ± 
0.01 
0.85 ± 
0.01 
Ornithine ND ND ND ND 0.19 ± 
0.01a 
0.21 ± 
0.01a 
0.19 ± 
0.01a 
0.15 ± 
0.01b 
0.46 ± 
0.18 
0.50 ± 
0.17 
0.59 ± 
0.24 
0.51 ± 
0.17 
ND; not detected 
Values are mean ± SEM of n = 8 rats/group. Different superscript letters a and b within the same row indicate significant difference at 
p<0.05 by One-way ANOVA followed by Tukey’s test  
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Table 4. Body composition of female rats fed 10% protein diets consisting of carp sarcoplasmic protein, casein, whey protein isolate, 
or 2 weeks on 10% casein diet followed by a no-protein diet. 
Tissue CSP Casein WPI No-Protein 
Wet Weight (g)         
Liver 8.45 ± 0.47a 8.48 ± 0.35a 9.54 ± 0.52a 5.4 ± 0.19b 
Gastrocnemius Muscles 0.95 ± 0.03a 0.96 ± 0.05a 1.08 ± 0.07a 0.73 ± 0.05b 
Soleus Muscles 0.47 ± 0.03ab 0.52 ± 0.02a 0.41 ±0.03ab 0.48 ± 0.02b 
Gonadal Fat Pad 2.62 ± 0.46b 3.26 ± 0.53ab 5.10 ± 0.68a 1.47 ± 0.35b 
Retroperitoneal Fat Pad 1.85 ± 0.48ab 1.66 ± 0.44ab 2.22 ± 0.39a 0.30 ± 0.08b 
Right Kidney 0.88 ± 0.03a 0.82 ± 0.02a 0.93 ± 0.03a 0.59 ± 0.04b 
Left Kidney 0.89 ± 0.02ab 0.82 ± 0.02b 0.95 ± 0.03a 0.65 ± 0.05c 
Heart 0.89 ± 0.03a 0.97 ± 0.09a 0.93 ± 0.04a 0.63 ± 0.03b 
Lungs 1.45 ± 0.08ab  1.42 ± 0.08ab  1.51 ± 0.06a 1.20 ± 0.08b  
Brain 1.79 ± 0.04 1.62 ± 0.05 1.73 ± 0.09 1.72 ± 0.04 
Adrenals 0.94 ± 0.33ab  0.67 ± 0.24ab  1.38 ± 0.39a  0.21 ± 0.06b  
Thymus 0.64 ± 0.07a 0.61 ± 0.04a 0.61 ± 0.09a 0.35 ± 0.04b 
Spleen 0.43 ± 0.02a 0.46 ± 0.02a 0.52 ± 0.03a 0.27 ± 0.02b 
Values expressed as mean ± SEM of n=8 rats/group. Different superscript letters a and b within the same row indicate significant 
difference at p<0.05 by One-way ANOVA followed by Tukey’s test.  
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Table 5. Measurements of kidney and bone health in female rats fed 10% protein diets consisting of carp sarcoplasmic protein, casein, 
whey protein isolate, or 2 weeks on 10% casein diet followed by a no-protein diet. 
  CSP Casein WPI No-Protein 
Kidney Health Markers     
Urinary Calcium Excretion (mg/week) 9.93 ± 3.95 21.72 ± 6.01 24.07 ± 8.36 10.19 ± 2.36 
Kidney Total Calcium (mg/g) 0.36 ± 0.03b 0.45 ± 0.01ab 0.46 ± 0.02ab 0.56 ± 0.04a 
Serum     
Blood Urea Nitrogen (mg/dL) 9.63 ± 1.55 11.50 ± 0.65 11.53 ± 2.09 10.01 ± 1.13 
Calcium (mg/dL) 9.30 ± 0.43ab 10.50 ± 0.55a 10.48 ± 0.33a 8.51 ± 0.43b 
Albumin (g/dL) 4.11 ± 0.16a 4.16 ± 0.28a 4.19 ± 0.49a 2.63 ± 0.17b 
Creatinine (mg/dL) 1.45 ± 0.05 1.40 ±0.08 1.39 ± 0.05 1.53 ± 0.11 
Bone Health Markers     
Morphometry     
Femoral Length (mm) 27 ± 0.16a 26 ± 0.57a 26 ± 0.56a 22 ± 0.92b 
Femoral Width (mm) 3.8 ± 0.04a 3.7 ± 0.06a 3.8 ± 0.04a 3.5 ± 0.05b 
Femoral Depth (mm) 2.8 ± 0.04a 2.8 ± 0.04a 2.8 ± 0.04ab 2.6 ± 0.04b 
Femoral Dry weight (g) 0.549 ± 0.01a 0.51 ± 0.03a 0.491 ± 0.03a 0.363 ± 0.03b 
Mineralization     
Femoral Total Mineral Content (mg/bone) 190.27 ± 3.17a 178.46 ± 8.21a 173.96 ± 8.12a 128.80 ± 7.53b 
Femoral Total Calcium (mg/g bone) 123.63 ± 2.59 127.22 ± 3.90 129.99 ± 3.12 129.73 ± 4.36 
Femoral Total Phosphorous (mg/g bone) 73.42 ± 1.21 73.57 ± 1.24 77.18 ± 1.44 75.76 ± 2.08 
Bone Strength     
Femoral Peak Force (N) 126.68 ± 4.39 129.01 ± 6.40 137.98 ± 4.29 117.00 ± 7.08 
Femoral Ultimate Bending Stress 
(N/mm2) 38.41 ± 1.37 38.88 ± 2.71 42.18 ± 1.48 35.65 ± 2.78 
Ultimate Stiffness (N/s) 440.46 ± 20.06 465.25 ± 21.45 459.95 ± 15.89 392.550 ± 33.44 
Young’s Modulus (N/mm2) 2415.09 ± 124.99 2412.66 ± 140.52 2253.64 ± 127.73 1985.59 ± 239.67 
Values expressed as mean ± SEM of n=5-8 rats/group. Different superscript letters a and b within the same row indicate significant 
difference at p<0.05 by One-way ANOVA followed by Tukey’s test.  
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Figure 1: Body weights of female rats fed 10% protein diets consisting of carp sarcoplasmic protein, casein, whey protein isolate, or 2 
weeks on 10% casein diet followed by a no-protein diet. Values are mean ± SEM of n = 8 rats/group. Letters (a, b, c) shows 
significant difference at p<0.05 determined by ANOVA followed by Tukey’s HSD.  
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Supplemental Tables  
 
Supplemental Table 1: Body composition corrected for body weight of female rats fed 10% 
protein diets consisting of casein, whey protein isolate, carp sarcoplasmic protein, or 2 weeks on 
10% casein diet followed by a no-protein diet. 
Tissue CSP Casein WPI 
No-
protein 
Relative Weight (g tissue/g body 
weight) 
    
Liver 4.15 ± 0.18 4.10 ± 0.14 
4.18 ± 
0.17 
3.89 ± 
0.15 
Gastrocnemius Muscles 0.47 ± 0.02 0.46 ± 0.03 
0.49 ± 
0.03 
0.48 ± 
0.02 
Soleus Muscles 0.23 ± 0.01 0.26 ± 0.01 0.22 ± .01 
0.25 ± 
0.02 
Gonadal Fat Pad 
1.28 ± 
0.22b 
1.57 ± 
0.25ab 
2.31 ± 
0.31a 
1.06 ± 
0.25b 
Retroperitoneal Fat Pad 
0.91 ± 
0.24ab 
0.80 ± 
0.22ab 
1.01 ± 
0.18a 
0.28 ± 
0.05b 
Right Kidney 0.43 ± 0.01 0.4 ± 0.01 
0.43 ± 
0.02 
0.39 ± 
0.02 
Left Kidney 0.44 ± 0.01 0.40 ± 0.01 
0.43 ± 
0.01 
0.41 ± 
0.02 
Heart 0.45 ± 0.02 0.47 ± 0.01 
0.42 ± 
0.02 
0.46 ± 
0.02 
Lungs 0.76 ± 0.05 0.69 ± 0.03 
0.72 ± 
0.04 
0.86 ± 
0.06 
Brain 
0.88 ± 
0.02b 
0.79±0.03b 
0.84 ± 
0.06b 
1.19 ± 
0.05a 
Adrenals 0.01 ± 0.01 0.01±0.01 
0.01 ± 
0.01 
0.01 ± 
0.01 
Thymus 0.32 ± 0.03 0.30±0.02 
0.28 ± 
0.04 
0.25 ± 
0.03 
Spleen 0.21 ± 0.19 0.22±0.01 
0.24 ± 
0.01 
0.20 ± 
0.02 
Values expressed as mean±SEM of n=8 rats/group. Different superscript letters a and b within 
the same row indicate significant difference at p<0.05 by One-way ANOVA followed by 
Tukey’s test 
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Abstract  
Consumption of high protein, milk-based infant formulas have been reported to increase 
body weight gain and later life obesity risk resulting in the recommendation to lower protein 
content. However, protein deficiency has been characterized by stunting and fatty liver due to 
altered liver lipid metabolism. The objective of this study was to assess the effect low protein 
diets from different sources on hepatic and adipose tissue lipid metabolism compared to a protein 
deficient diet. Young (age 28 days) female Sprague-Dawley rats were randomly assigned (n=8 
rats/group) to standard purified diet with 10% kcal protein as casein, whey protein, carp 
sarcoplasm protein (CSP) or a protein deficient diet. Results showed whey-fed rats had the 
greatest (p < 0.05) body weight and adiposity; however, there were no differences in gene 
markers of lipogenesis, lipolysis or triglyceride synthesis and transport in adipose tissue. Casein-
fed rats showed an anti-inflammatory response in adipose tissue indicated by upregulation of (p 
< 0.05) of COX-2 and interleukin-10. Hepatic histology showed greater (p < 0.05) hepatic fat 
infiltration were observed in rats fed the protein deficient diet while no differences in fat 
infiltration among rats consuming CSP, casein or whey. Hepatic lipoprotein lipase (LPL) of 
casein-fed rats was the only significantly (p < 0.05) altered biomarker in response to adipose 
interleukin-10 production. Collectively, results indicate lower protein diets containing CSP and 
casein is a physiologically safe option and may be preferable to whey protein for preventing 
increased adiposity and with minimal alterations to gene expression.  
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1. Introduction 
Global fisheries currently operating close to maximal levels are at risk depleting fish 
stocks (FAO, 2016). According to the Fishes and Aquaculture Organization (FAO), expansion of 
aquaculture industries decreased by 3.3 %, while the global human populations is expected to 
increase to 10 billion by 2050 (FAO, 2016). A potential solution to ensure fisheries sustainability 
is to promote use of less desirable fish species and fish processing by-products. 
Silver carp (Hypophthalmichthys molitrix) was imported into the United States in the 
1970s to control algal growth in aquaculture and for sewage treatment ponds. Due to 
unintentional introduction into the wild, carp has become an invasive species spreading into 
various habitats and disrupting existing ecosystems (Chick 2001). Despite its abundance, silver 
carp are underutilized as a food source due to their boniness making consumption and processing 
into edible products difficult. A proposed solution to the problem of this invasive fish species is 
to develop carp into a protein supplement for human consumption. Previous research 
investigated the recovery of sarcoplasm protein from carp wash water and in vitro characteristics 
of the resulting protein-rich silver carp sarcoplasmic protein powder (CSP) (Warren et al. 2018). 
Subsequently, an animal feeding study showed CSP powder protein quality, bioavailability, 
growth, and safety were comparable to commercially popular milk proteins, casein and whey 
protein isolate (Warren et al., 2020). 
Although, casein and whey protein have been used in infant formulas with long-term 
commercial success compared to human milk, infant formulas often have higher protein content 
(Tang, 2018).  Higher body weight gains are common in formula-fed infants and has been 
attributed to the higher protein content (Ong et al., 2009). This is a health concern since weight 
gain during the first year of life has been suggested to be one of the strongest indicators of future 
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risk of obesity (Ong & Loos, 2006). Previous research has reported whey-based formulas 
promoted greater body weight gains by enhancing hepatic insulin like growth factor 1 (IGF-1) 
secretion which mediates lipid synthesis in adipose tissue (Ong et al.,2009; O’Connell, 2013). 
However, by lowering protein content of infant formulas this may be detrimental to growth and 
liver function. 
 Protein-energy malnutrition is defined as an imbalance between intake of protein and 
energy and the amount required for optimal growth, development, and function (Fock et al., 
2010; Bossola, 2015). Protein-energy malnutrition has been reported to alter liver histology and 
biochemical characteristics (Caballero et al., 2015; Feres et al., 2010). Gomes and others (2017) 
reported reduced liver weight and hepatocyte volume in protein undernourished mice. Further, 
protein energy malnutrition has been characterized by fatty liver and hepatic dysfunction 
(Zutphen et al., 2016). When the quantity of dietary protein is reduced, protein quality and 
digestibility becomes more important for sustaining growth and metabolic function. Koletzko 
and others (2009) reported infants fed diets containing high quality proteins in lower amounts 
supported normal growth while reducing the risk of obesity development later in life.  
The protein composition of wild carp was found to be 16.69% and to contain all 10 
essential amino acids in quantities required for human needs (Ljubojević, 2017). Additionally, 
marine derived proteins have been suggested to lower cardiovascular risk. An animal feeding 
study found marine proteins reduced total serum cholesterol compared to casein by increased 
cholesterol and bile acid fecal excretion (Narayan et al., 2009). Fish protein derived from cod 
was found to lower liver triglyceride content and secretion compared to casein (Demonty et al., 
2003). In addition to its protein content, wild carp can have 7.13% lipid content with 72.64% of 
fatty acids consisting of polyunsaturated fatty acids (PUFAs) with health-beneficial omega-3 
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PUFAs (ω-3 PUFAs) being particularly abundant at 5.97% (Ljubojević, 2017). Omega-3 PUFAs 
are often added to infant formulas for infant growth and development of visual and cognitive 
function (Gil et al., 2003). Further, ω-3 PUFA supplementation has been reported to improved 
fatty liver and hepatic dysfunction clinical markers in a meta-analysis of 18 studies consisting of 
1,424 patients.  
The objective of this study was to assess the effect of providing a low protein diet (10 % 
kcal) consisting of CSP or commercial milk protein powders, whey and casein, on lipid 
metabolism in liver and adipose tissue compared to a protein deficient diet using a rat model. We 
hypothesize a low protein diet comprised of CSP will alter lipid metabolism resulting in reduced 
adiposity and hepatic lipid accumulation compared to casein and whey protein.  
2. Materials and Methods 
2.1 Animals and Diets  
All animal procedures were approved by West Virginia University’s Animal Care and 
Use Committee and performed in accordance with National Research Council for the Care and 
Use of Laboratory Animals Guidelines (National Research Council 1996). Immature (age 28 
days) female Sprague-Dawley rats (n=32) were purchased from Charles River (Worcester, MA) 
and individually housed in metabolic cages for the duration of the four weeks study. Following 
7-day acclimation, rats (n=32) were randomly assigned to four diet treatment groups (n = 8 
rats/group) consisting of purified standard rodent diet AIN-93G (American Institute of Nutrition-
93Growth) containing 10% kcal protein from different sources: (1) CSP for 4 weeks, (2) casein 
for 4 weeks, (3) whey protein isolate for 4 weeks or, (4) a protein deficient diets comprised of 
AIN-93G with 10% kcal casein for 2 weeks followed by protein deficient diet for the remaining 
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2 weeks. Diet ingredients and composition are provided in Table 1. All experimental diets were 
adjusted to be isocaloric (3.7-3.8 kcal/g).  
Following establishment of a standard average food intake, rats were peer fed.  To avoid 
difference in caloric intake, rats were provided 16 ± 0.2 g diet daily. All diets and proteins, 
casein and whey protein isolate were purchased from Envigo-Teklad (Madison, WI). Diets were 
stored at -20oC until fed. Rats were provided deionized, distilled water (ddH2O) ad libitum. Body 
weight and ddH2O intake were measured weekly. 
Following 4 weeks of feeding, rats were fasted overnight (12 h) and euthanized via 
carbon dioxide inhalation. Liver and gonadal fat pad were dissected. Tissues were weighed, flash 
frozen in liquid nitrogen, and stored at -80oC for later analysis. 
2.2 Diet and Tissue Lipid Content 
 Lipids were extracted from the experimental diets and tissues according to methods 
described by Bligh and Dyer (1959). Briefly, experimental diets (1.0g) liver tissue (1.0g) and 
gonadal adipose tissue (0.5 g) were homogenized in Tris/EDTA buffer (pH 7.4). Nonadecanoic 
acid (50 µL) was added as an internal standard for fatty acid quantification followed by the 
addition of a chloroform: methanol: acetic acid solution (2:1:0.15, v/v/v). Samples were 
centrifuged at 900×g for 10 minutes at 10oC, and the chloroform layer (bottom layer) was 
collected and filtered. The filtered chloroform layer was mixed with a chloroform:methanol 
solution (4:1, v/v), centrifuged at 900×g for 10 minutes at 10oC, and the resulting chloroform 
layer was collected and filtered. Extracted lipids were dried under nitrogen gas and total lipid 
content was determined gravimetrically. 
2.3 Diet and Tissue Fatty Acid Composition 
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 Following lipid extraction, fatty acids were transmethylated as described by Fritsche and 
Johnston (1990). Briefly, fatty acids were methylated by adding a solution of 4% sulfuric acid in 
anhydrous methanol to samples of extracted lipids. Samples were incubated for 60 minutes in a 
90oC water bath, cooled to room temperature, and then the reaction was stopped using ddH2O. 
Chloroform was added to the methylated samples and centrifuged at 900 x g for 10 minutes at 
10oC. To remove remaining water, the collected chloroform layer was filtered through anhydrous 
sodium sulfate. Fatty acid methyl esters (FAMEs) were dried under nitrogen gas, resuspended in 
isooctane, and stored at -20oC until analysis. 
 Fatty acid methyl esters (FAMEs) were analyzed using gas liquid chromatography (CP-
3800; Varian, Walnut Creek, CA, USA). This involved an initial temperature of 140oC for 5 
minutes increased by 1oC per minute to a final temperature of 220oC. FAMEs were separated 
with a wall-coated open tubular fused silica capillary column (Varian, Walnut Creek, CA, USA) 
with a CP-Sil 88 stationary phase and a nitrogen carrier gas. Total separation time was 56 
minutes. To identify fatty acids, quantitative 37 Component FAMEs Sigma Mix (Supelco, 
Bellefonte, PA) was used. Fatty acid identities were determined by retention time, quantified 
using peak area counts, and reported as percent of total fatty acids. 
2.4 Liver Histology 
The left lateral lobe of the liver (n = 3) was removed and placed in 10% buffered 
formalin for histology analysis. Extracted tissues were dehydrated with solutions of increasing 
ethanol concentration (70-100%) in ddH2O then placed in xylene and embedded in paraffin. 8µm 
sections from each were stained with eosin and hematoxylin. Hepatic fat accumulation was 
graded using classification provided in Brunt, et al. (1999). Grade 0 indicated no presence of fat 
vacuoles, grade 1 indicated fat vacuole presence in less than 33% of hepatocytes, grade 2 
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indicated presence in 33-66% of hepatocytes, and grade 3 indicated evidence of fat vacuoles in 
greater than 66% of hepatocytes. Slides were analyzed with a Nikon TE 2000-S light microscope 
(Nikon Instruments, New York, NY) at 10x magnification by a trained investigator blinded to 
group identities. Images were captured using a PC interface with Q-Capture imaging software 
(Quantitative Imaging Corporation, BC, Canada). 
2.5 RNA isolation and gene expression 
Total RNA was extracted from frozen liver and gonadal adipose tissue using the Zymo 
Research mRNA Isolation Kit (Irvine, CA, USA) according to manufacturers’ instructions. 
Isolated RNA was quantified by spectrophotometry (NanoDrop 100; Thermo Scientific, 
Waltham, MA, USA) and integrity was visualized on a 1.5% agarose gel. Isolated RNA was 
treated with DNase I with a TURBO DNA-free kit (Applied Biosystems, Foster City, CA, USA).  
Real-time quantitative polymerase chain reaction (RT-qPCR) was used to amplify total 
mRNA using the Superscript III First-Strand Synthesis System with oligo dT primers for 
Carbohydrate-response element-binding protein (ChREBP), Sterol regulatory element-binding 
protein-1c (SREBP-1c), Sterol regulatory element-binding protein-2 (SREBP-2), fatty acid 
synthase (FAS), Stearoyl-CoA desaturase-1 (SCD-1), Peroxisome proliferator-activated receptor 
alpha (PPARα), peroxisome proliferator-activated receptor gamma (PPARγ), hormone sensitive 
lipase (HSL), diacylglycerol O-acyltransferase 2 (DGAT2), lipoprotein lipase (LPL), microsomal 
triglyceride transfer protein (MTTP), cyclooxygenase 2 (COX-2), interleukin 10 (IL-10), and 
nuclear factor kappa-light-chain-enhancer of activated B cells (NFκB). House-keeping genes 
included β-actin and GAPDH (Invitrogen, Carlsbad, CA, USA). Primers were designed using the 
Primer3 program (Howard Hughes Medical Institute) and respective mRNA sequences from the 
NCBI database. Forward and reverse primers for gene transcription are provided in Table 1. 
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RT-qPCR of liver and gonadal adipose tissues used 2.5 µL of SYBR Green Master Mix 
(Applied Biosystems, Foster City, CA, USA), 1 µL of cDNA (diluted 1:10), 1 µL of forward and 
reverse primer solutions (10 µM each), and 0.5 µL ddH2O for a 5 µL total reaction volume. 
Thermal cycling included 2 minutes at 50oC, 10 minutes at 95oC, and then 40 cycles of 15 
seconds at 95oC and 1 minute at 60oC.  A melt curve analysis was utilized following cycling.  
2.6 Serum Biochemical Markers 
Prior to euthanasia by carbon dioxide inhalation, rats were fasted overnight. Blood was 
collected by cardiac puncture and centrifuged at 1500 × g at 4°C for 10 min to separate serum. 
Serum was collected and stored at -80°C until analyzed. Alanine aminotransferase (ALT) and 
aspartate aminotransferase (AST) were measured to assess hepatic function by enzymatic 
colorimetric assays using a commercially available Vet- 16 rotor. Absorbance was measured at 
595 nm by Hemagen Analyst automated spectrophotometer (Hemagen Diagnostics Inc., 
Columbia, MD).   
A commercially available fluorometric assay (Cell Biolabs, San Diego, CA, USA) was used 
to determine serum total cholesterol (TC), low-density lipoprotein-cholesterol (LDL-C/VLDL-
C), and high-density lipoprotein-cholesterol (HDL-C). Briefly, serum (200 µL) was mixed with 
precipitation reagent (200 µL) and centrifuged for 20 minutes at 2000 × g. The HDL-C 
containing supernatant was collected and diluted (1:50) with reaction buffer. The LDL-C/VLDL-
C pellet was resuspended and diluted (1:50) with reaction buffer. Samples were transferred into a 
96-well plate and incubated for 45 minutes. Excitation at 570 nm and emission at 590 nm was 
measured with a microplate reader (BioTek Instruments Inc., Winooski, VT).  
 A colorimetric assay purchased from Cayman Chemical (Ann Arbor, MI, USA) was used 
to determine serum triglycerides. Briefly, serum samples (10 µL) were aliquoted in duplicate into 
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a 96-well plate and mixed with 150 µL of diluted enzyme solution to imitate the reaction. 
Following bench top incubation for 45 minutes, absorbance at 540 nm was measured using a 
microplate reader (BioTek Instruments Inc., Winooski, VT). 
2.7 Statistical Analysis 
 All results are expressed as mean ± standard error of the mean (SEM). Gene expression 
was analyzed as a function of mRNA abundance (A) using the following formula derived from 
Jacometo et al. (2014): 
𝐴 = 1
1
𝐸𝑔.𝑜.𝑖 𝐶𝑇,𝑔.𝑜.𝑖. − 𝐸ℎ.𝑘.𝐶𝑇,ℎ.𝑘.
 
Where Eh.k.CT,h.k. is the average of the expression of the housekeeping genes: 
𝐸ℎ.𝑘.𝐶𝑇,ℎ.𝑘. = 0.5 (𝐸𝐺𝐴𝑃𝐷𝐻𝐶𝑇,𝐺𝐴𝑃𝐷𝐻 + 𝐸𝐴𝐶𝑇𝐵𝐶𝑇,𝐴𝐶𝑇𝐵) 
Data for each treatment group was log-transformed prior to statistical analysis and 
significant differences were determined by one-way analysis of variance (ANOVA). Post-hoc 
Tukey’s test was used with p < 0.05 signifying statistically significance. Statistical analyses were 
performed using SAS JMP Pro 12.0 (SAS Institute Inc., NC, USA). 
3. Results 
3.1 Fatty Acid Composition of Diets 
As shown in Table 2, fat content of all experimental diets was ≈7 % kcal. The fatty acid 
profile of experimental diets is shown in Table 3. Palmitoleic acid (16:1) was present in the CSP 
diet, but not the other protein diets. There was no other significant difference in saturated fatty 
acid (SFAs), monounsaturated fatty acid (MUFAs), or essential fatty acid, linoleic acid and α-
linoleic acid, content between any of the experimental diets. Arachidonic acid, eicosapentaenoic 
acid, and docosahexaenoic acid were determined to be negligible in all experimental diets.  
3.2 Food Intake, Body Weight and Tissue Weight 
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Feeding whey protein for 4 weeks resulted in greater (p < 0.05) final body weight 
compared to CSP and casein. There were no body weight differences between the casein and 
CSP-fed rats. Body weight was significantly reduced in rats provided a protein deficient diet for 
two weeks (Figure 1). There were no differences in total diet intake and caloric intake among 
dietary protein groups.  However, feed efficiency was significantly greater (p < 0.05) in rats fed 
whey protein compared to rats fed CSP. Rats fed a protein deficient diet had the lowest (p < 
0.05) feed efficiency (Table 4).  
Rats fed whey protein had greater (p < 0.05) gonadal fat pad weight compared to rats fed 
CSP and protein-free diet. Liver weight was significantly heavier (p < 0.05) for rats fed 10% 
protein as CSP, casein, and whey protein compared to the protein deficient group. However, 
differences were no longer significant after corrected for body weight. 
3.3 Liver Histology 
Liver histology identified <33% fat vacuoles in the hepatocytes in 100% of rats fed CSP 
compared to 33% of rats fed casein or whey protein. Greatest hepatic fat infiltration was 
observed in rats fed the protein deficient diet. In the protein deficient group, approximately 33% 
of rats showed 33–66% fat vacuoles in hepatocytes and 66% showed fat vacuoles in <66% of 
hepatocytes (Figure 3). There was an overall significant (p=0.0327) difference among histology 
scores.  
3.4 Liver Lipid Content and Fatty Acid Composition 
As shown in Table 5, rats fed the protein deficient diet had greater (p < 0.05) total 
hepatic lipid content compared to rats fed 10% protein as either CSP, casein or whey-protein. 
Rats fed a protein deficient diet had the lowest hepatic stearic acid (18:0) content and the highest 
(p < 0.05) hepatic oleic acid (18:1), linoleic acid and α-linoleic content. The liver of rats fed 
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protein deficient diet contained arachidonic acid (0.14 ± 0.03) but was negligible in the hepatic 
tissue of protein-fed rats. There were no differences (p > 0.05) in total lipid content and fatty acid 
composition among rats fed different protein sources.   
3.5 Hepatic Gene Expression 
 As shown in Table 6, gene expression of hepatic LPL was upregulated (p < 0.05) in rats 
consuming casein. Conversely, consumption of the protein deficient diet downregulated (p < 
0.05) hepatic LPL expression. There were no differences in expression of genes involved in 
lipogenesis (ChREBP, SREBP-1c, SREBP-2, FAS, SCD-1), lipolysis (PPARα, PPARγ, HSL) or 
expression of genes regulating triglyceride synthesis and transport (DGAT2, MTTP)  
or inflammation (COX-2, IL-10, NFκB). 
3.6 Adipose Lipid Content and Fatty Acid Composition 
Shown in Table 7, there was no significant difference in gonadal adipose tissue total lipid 
content or adipose tissue fatty acid composition among experimental diet groups.  
3.8 Adipose Gene Expression 
 Shown in Table 8, there were no differences in expression of genes involved in lipogenesis 
(ChREBP, SREBP-1c, SREBP-2, FAS, SCD-1), lipolysis (PPARα, PPARγ, HSL), or 
triglyceride synthesis and transport genes (DGAT2, LPL, MTTP) among the experimental diet 
groups. Adipose COX-2 expression was downregulated (p < 0.05) in rats fed CSP and protein 
deficient diets. Gene expression of COX-2 was upregulated (p < 0.05) in adipose tissue of rats 
consuming casein. Additionally, gene expression of IL-10 was upregulated (p < 0.05) in adipose 
tissue of rats fed casein diet. Adipose IL-10 expression was downregulated (p < 0.05) in rats 
consuming protein deficient diet. There were no gene expression differences in inflammatory 
transcription factor (NFkB) among experimental diet groups. 
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3.9 Serum Liver Enzymes, Cholesterol, and Triglycerides 
Shown in Table 9, there were no significant differences in serum AST, ALT among 
experimental diet groups. There were also no significant differences in serum triglycerides, total 
cholesterol, HDL-C, and VLDL/LDL-C among experimental diet groups. 
4 Discussion 
4.1 Growth Parameters 
As expected, growing rat fed the protein deficient (0% kcals) diet for 2 weeks had the 
lowest body weight. Growing rats fed a low (10% kcal) protein diet derived from either fish or 
dairy sources supported growth within the normal range according to the body weight chart for 
female Sprague-Dawley provided by the animal vendor (Charles River, Worcester, MA). 
However, rats fed whey protein had significantly heavier final body weights and gonadal adipose 
compared to rats fed CSP despite no differences in caloric intake. Feeding growing rats 20% kcal 
protein diets, Liaset and others (2009) reported higher body weight gain, but no differences in 
adipose tissue weight in rats fed casein compared to fish protein. Whey protein was not 
investigated. In the current study, higher gonadal adipose (p < 0.05) in rats fed whey protein 
compared to CSP may be due to higher feed efficiency. Whey proteins remain soluble in the 
stomach and pass rapidly into the intestine leading rapid delivery rates for peptides and amino 
acids (Boirie et al., 1997). However, high whey protein intake has been suggested to contribute 
weight gain in early life. Early weight gain has been reported to be one of the best indicators of 
later risk of obesity (Ong & Loos, 2006). 
 In the current study, diets were isocaloric and nutrients were adjusted to have no 
differences in dietary lipid content or fatty acid composition between experimental diets: 
therefore, phenotypic differences were due to differences in protein sources. Amino acid analysis 
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of our diets showed whey protein had the highest leucine and isoleucine content (Warren et al., 
2020). Branch chain amino acids have been reported to promote adipogenesis by stimulating 
insulin and insulin like growth factor-1 (IGF-1) (Melnik, 2012). Additionally, leucine and 
isoleucine play an important role in the synthesis of proteins and other nitrogenous compounds 
that include molecules that regulate lipid metabolism (Nie et al., 2018). Based on the current 
study results, growing rats fed a low protein diet as CSP was adequate to support growth and 
decreased adipogenesis compared to whey protein.  
4.3 Adipose Lipid Metabolism 
  To determine molecular mechanisms that may have contributed to adiposity in whey-fed 
rats; we measured genes with potential to modulate adipose lipid content (hypertrophy) and 
differentiation (hyperplasia). Peroxisome proliferator-activated receptors (PPARs) belong to a 
ligand-activated nuclear hormone receptor superfamily and are known to regulate the expression 
of numerous genes involved in fatty acid metabolism and adipocyte differentiation (Schoonians 
et al., 1996). PPARγ is mainly expressed in adipose tissue where it has been shown to be an 
essential component in adipocyte differentiation (Braissant et al., 1996; Tontonoz et al., 1994). 
Our study found no differences in gene expression of PPARγ among diet groups suggesting 
greater gonadal adipose tissue weight in rats fed whey protein was not the results of increased 
adipose differentiation. 
Lipid content of adipose tissue in rats provided the protein deficient diet were 
numerically lower than whey and CSP-fed rats. Regulation of DNL is mainly at the 
transcriptional level. Transcription factors SREBP-1c induces fatty acid synthesis and SREBP-2 
is primarily responsible for cholesterol uptake (Song et al., 2018). The present study showed rats 
fed a deficient or low protein diet from different sources had no significant effect on SREBP-1c 
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and SREBP-2 gene expression. This is because SREBP role in adipocyte DNL is minor. Instead, 
ChREBP is a major lipogenic transcription factor in adipocyte DNL (Song et al., 2018). In DNL, 
the key rate-limiting enzyme FAS converts malonyl-CoA into the first fatty acid product in DN, 
palmitic acid. In turn, palmitic acid (16:0) undergoes elongation to stearic acid (18:0) and 
desaturation by SCD-1 to palmitoleic acid (16:1) and oleic acid (18:1). Feeding 0% protein or 
10% casein, CSP, and whey protein diets had no significant effect on adipose ChREBP, FAS, 
SCD-1 gene expression or end products: palmitic, stearic, palmitoleic and oleic acid content.  
DNL is balanced by lipolysis and therefore, a reduction in adipocyte lipolysis may 
contribute to hypertrophy. In the current study, rats fed low casein, CSP, and whey protein diets 
had no significant effect on gene expression of HSL and PPARα in gonadal adipose. Absence of 
significance may be because PPARα has been reported to play a more important role in brown 
rather than white adipose tissue in rats (Barbera et al., 2001; Atgie et al., 1997). In our study 
there were also no difference among experimental diet groups in expression of genes regulating 
triglyceride synthesis, transport, and storage, DGAT2, MTTP, and LPL. Blais et al. (2017) 
evaluated changes induced by reducing dietary protein from standard 20% to low 6% kcal using 
either soy protein or casein. The low soy protein was lower in methionine (230 g) compared to 
casein (1.03 g) and showed increased energy expenditure (Blais et al., 2017). In our study, 
absence of differences in adipose DNL markers may be attributed to methionine content of the 
CSP, casein and whey protein diets of 17, 27, and 24 mg/g protein, respectively (Warren et al., 
2020).  
There was no significant difference in gene expression of NFκB transcription factor 
regulating COX-2 in the adipose tissue of rats fed CSP protein compared to whey protein or 
casein. However, a review conducted by Liddle et al. (2017) suggested eicosapentaenoic acid 
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and docosahexaenoic consumption shifts the adipose tissue immune cell population toward a less 
inflammatory phenotype as suggested by the reduced macrophage ratio and increased anti-
inflammatory IL-10 production. In the present study, there were no significant differences in IL-
10 between rats fed 10% protein as either CSP, whey protein or casein. However, gene 
expression of IL-10 was upregulated (p < 0.05) in rats fed casein compared to rats fed a protein 
deficient diet.  
Collectively, results indicate low dietary protein provided from dairy or fish source had 
minimal effects on adipose lipid metabolism and inflammation in growing rats. However, 
Pezeshski et al. (2016) reported immature obesity-prone Sprague-Dawley rats fed protein 
restricted diets consisting of 10% kcal egg protein resulted in greater liver fat content indicative 
of hepatic steatosis despite lack of increased total body fat. Therefore, the present study also 
investigated the effects of low protein diets from different sources on hepatic lipid metabolism in 
using immature Sprague-Dawley rats.  
4.2 Liver Metabolism  
NAFLD is defined as fat vacuoles in > 5% of hepatocytes evaluated by light microscopic 
examination of a hematoxylin and eosin stained liver section (4–5 μm thick) under a 10× 
objective lens (Sanyal et al., 2011). In the present study, all rats showed evidence of NAFLD. 
Rats fed the protein deficient diet showed the greatest accumulation of lipids in the liver as 
evident by the majority of rats having fat vacuoles in >66% of hepatocytes and the greatest (p < 
0.05) hepatic total lipid content. Hepatic fat infiltration was lower in rats fed low protein diets 
with fat vacuoles in <33% of hepatocytes. Further, hepatic fat infiltration differed depending on 
protein source. Rats fed casein and whey protein showed less evidence of liver steatosis 
compared to rats fed CSP.  
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NAFLD has been characterized by liver steatosis and dysregulation of lipid metabolism 
(Lonardo et al., 2015). ChREBP, SREBP-1c and SREBP-2 are transcription factors involved in 
the regulation of DNL. Hepatic DNL is initiated with FAS producing the SFAs, palmitic (16:0) 
and stearic acids (18:0). Subsequently, SCD-1 can desaturate these fatty acids producing 
MUFAs, palmitoleic (16:1n-7) and oleic acids (18:1n-9). In our study, hepatic fatty acid 
composition showed rats fed the protein deficient diet had lower (p < 0.05) stearic acid and 
greater oleic acids than protein-fed rats. However, rats fed the protein deficient diets did not 
exhibit differences in expression of DNL gene markers compared to the protein-fed groups. 
Additionally, DNL transcription factors and enzymes gene expression did not differ among the 
protein-fed rats regardless of source. Subsequently, there were also no differences in liver DNL 
end products: palmitic, stearic, palmitoleic, or oleic acids among rats fed protein diets.  
In the absence of DNL alterations, reduced lipolysis may explain the greater liver 
steatosis. In lipolysis, HSL catalyzes the conversion of diacylglycerols to monoacylglycerols 
(Lee et al., 2015). In the liver, transcription factors, PPARα and PPARγ, regulate of lipolysis and 
lipid oxidation. Upregulation of PPARα and PPARγ enhance the use of lipids for metabolism 
and have been targets for NAFLD therapeutics (Kersten et al., 2000; Fuchs et al., 2014). In the 
current study, there were no differences in expression in HSL PPARα and PPARγ among the 
experimental diet groups.  
Other key characteristics of NAFLD were dysregulation of triglyceride synthesis, 
transport, and storage (Romeo et al., 2008). DGAT2 is the rate limiting step in the biosynthesis 
of hepatic triglyceride production and increase DGAT2 activity contribute to liver steatosis 
(Wang et al., 2010). To prevent excessive liver storage, triglycerides are packaged into VLDL 
for transport to extrahepatic tissue by MTTP.  In our study, hepatic gene expression of DGAT2 
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and MTTP did not differ among diet groups. However, hepatic LPL expression was increased in 
the casein-fed rats compared to rats fed a protein deficient diet.  
LPL is the rate limiting enzyme in the hydrolysis of triglycerides in chylomicrons and 
VLDL that allows uptake of fatty acid acids by tissues (Goldberg, 1996). LPL is typically only 
found in extrahepatic tissues with greater concentrations found in adipose and muscle tissues 
(Semenkovich et al., 1989). In a human clinical study, Pardina et al. (2009) report in expression 
of hepatic LPL mRNA is significantly elevated in subjects with NAFLD compared to subjects 
with no liver disease. LPL overexpression in mouse liver causes liver-specific insulin resistance 
and exacerbates triglyceride accumulation in the liver (Kim et al., 2001). Therefore, our data 
suggests that rats consuming casein-based low protein diets may be at greater risk for the 
development of fatty liver. Furthermore, Hardardottir et al. (1994) reported that cytokines can 
induce liver LPL expression in adults.  
Inflammation and reactive oxygen species from fatty acid metabolism promotes NAFLD 
progression to non-alcoholic steatohepatitis (NASH) (Michelotti et al., 2013). The transcription 
factor NFκB, is a key regulator in COX-2 expression and subsequent pro-inflammatory 
responses (Lee at al., 2015; Lim et al., 2001). COX-2 catalyzes the conversion of arachidonic 
acid to pro-inflammatory prostaglandins. In our study, there were no differences in NFκB or 
COX-2 hepatic expression among experimental diet groups. Additionally, there were no 
differences in liver damage serum biomarkers ALT and AST among protein-fed rats. 
Additionally, NASH has been associated with lipoprotein dysregulation (Suzuki et al., 2017). 
However, in the present study, there were no differences in serum triglyceride, VLDL, and LDL 
levels among experimental diet groups. Absence of inflammation, hepatic damage, and lipid 
dysregulation in experimental diet groups indicated NAFLD did not progress to the more severe 
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NASH. Further suggesting low inflammatory status among the experimental groups, there were 
no differences in IL-10 expression. IL-10 has been suggested to be one of the most important 
anti-inflammatory cytokines (Stenvinkel et al., 2005).  
Conclusion  
Based on the results, CSP showed merit for commercial use in low protein formulas. Unlike 
whey protein, CSP consumption did not elevate body weight or adiposity. Instead, CSP 
demonstrated properties comparable to casein. Additionally, consumption of low CSP did not 
alter expression of genes regulating lipid metabolism as was observed in rats fed casein that 
contribute to NAFLD development or inflammation that promotes progression to NASH. Based 
on our animal study, CSP is not only a physiologically safe option, but may be preferable to 
whey protein for preventing increased adiposity. Branch chain amino acids in whey protein 
isolate may have stimulated insulin and IGF-1 resulting in adipogenesis. However, more studies 
are needed. Based on study results, sarcoplasm protein recovered from wash water from 
processing of carp, an invasive species could be marketed as a sustainable novel protein 
alternative to current commercial protein powder  
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6 Figure and Tables 
Table 1: List of primers used for RT-qPCR analysis. 
Gene NCBI Accession Number Forward Primer Reverse Primer 
ChREBP NM_133552.1 5' CCTTAATGGGATGGTGTCT 3' 5' AGAGCAGGGCAGGGAACAGTA 3' 
SREBP-1c NM_001276707.1 5' GCCTGCTTGGCTCTTCTCT 3' 5' GCTTGTTTGCGATGTCTCC 3' 
SREBP-2 NM_001033694.1 5' TGATGCCGACTCTACTGCTG 3' 5' CACGAAGACGCTCAAGACAA 3' 
FAS NM_017332.1 5' GCTGCTACAAACAGCACCATC 3' 5' TCCACTGACTCTTCACAGACCA 3' 
SCD-1 NM_139192.2 5' TTCGCCACTGACTTGCTATG 3' 5' CAGGAGGTTCTTGGGATGATT 3' 
PPARα NM_013196.1 5' ATGAACAAAGACGGGATGCT 3' 5' AGGAACTCTCGGGTGATGAA 3' 
PPARγ NM_013124.3 5' GCAAAGACAACAGACAAATCACC 3' 5' CGAAACTGGCACCCTTGA 3' 
HSL NM_012859.1 5' TCTCCAAGTGTGTAGCGCCTA 3' 5' AACTCCAGGAAGGAGTTGAGC 3' 
MTTP NM_001107727.1 5' TCAGGTGCTGTGTATTCTGCT 3' 5' CGTGTTCCACTTCCGTTCT 3' 
DGAT2 NM_001012345.1 5' CACCCTCCTGTGTATTCTGCT 3' 5' TTTGGCTGTTCTTGTTTCCA 3' 
LPL NM_012598.2  5' CGCTCCATCCATCTCTTCAT 3' 5' TTTCTCAAATGCCTCCTTGG 3' 
NFκB NM_001145138.2 5’ TTATGGGCAGGATGGACCTA 3’ 5’ CCTTTCAGGGCTTTGGTTTA 3’ 
COX-2 NM_017232.3 5’ CGGAGGAGAAGTGGGTTTTAG 3’ 5’ TGAAAGAGGCAAAGGGACAC 3’ 
IL-10 NM_012854.2 5’ CACTGCTATGTTGCCTGCTC 3’ 5’ GCCTTTGCTGGTCTTCACTC 3’ 
β-actin NM_031144.2 5' TTGCTGACAGGATGCACAAG 3' 5' CAGTGAGGCCAGGATAGAGC 3' 
GAPDH NM_017008.4 5' TCAAGAAGGTGGTGAAGCAG 3' 5' CCTCAGTGTAGCCCAGGATG 3' 
Abbreviations: ChREBP, carbohydrate-response element-binding protein; SREBP-1c, Sterol regulatory element-binding protein-1c; 
SREBP-2, Sterol regulatory element-binding protein-2; FAS, fatty acid synthase; SCD-1, Stearoyl-CoA desaturase-1; PPARα, 
Peroxisome proliferator-activated receptor alpha; PPARγ, peroxisome proliferator-activated receptor gamma; HSL, hormone sensitive 
lipase; DGAT2, diacylglycerol O-acyltransferase 2; LPL, lipoprotein lipase; MTTP, microsomal triglyceride transfer protein; COX-2, 
cyclooxygenase 2; IL-10, interleukin 10; NFκB, nuclear factor kappa-light-chain-enhancer of activated B cells; GAPDH, 
glyceraldehyde 3-phosphate dehydrogenase. 
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Table 2: Composition of rodent diets substituted with 10% kcal protein of  
    carp sarcoplasmic protein, casein or whey protein isolate.  
 
Treatments1 
CSP Casein Whey No-Protein 
Ingredient (g/kg)     
Whey Protein Isolate - - 111 - 
Casein - 115 - - 
Carp Protein 131.5 - - - 
Corn Starch 482.236 492.036 495.286 605.986 
Maltodextrin 132 132 132 132 
Sucrose 100 100 100 100 
Soybean Oil 66.5 70 70 70 
Cellulose 50 50 50 50 
Mineral Mix 13.4 13.4 13.4 13.4 
Calcium Phosphate 0.75 9.8 13.2 13.4 
Calcium Carbonate 11.1 5.25 2.6 2.7 
Vitamin Mix 10 10 10 10 
Choline Bitartate 2.5 2.5 2.5 2.5 
TBHQ, antioxidant 0.014 0.014 0.014 0.014 
Macronutrients (% kcal)     
Protein  10 10 10.3 0 
Carbohydrate  66.9 67.8 68.1 78.1 
Fat  7 7.1 7 7 
Calories (kcal/g) 3.7 3.8 3.8 3.8 
Abbreviations: CSP, carp sarcoplasmic protein; TBHQ, tert-butylhydroquinone 
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   Table 3: Fatty acid analysis of rodent diets substituted with 10% kcal protein of carp sarcoplasmic protein,  
  casein or whey protein. 
Measurements (%) 
Treatments1 
CSP Casein Whey No-Protein 
SFAs     
Palmitic acid 16:0 10.94 ± 0.73 10.61 ± 0.10 11.07 ± 0.16 10.98 ± 0.15 
Stearic acid 18:0 4.09 ± 0.27 3.87 ± 0.14 4.13 ± 0.05 3.92 ± 0.20 
MUFAs     
Palmitoleic acid 16:1 0.18 ± 0.09a 0.00 ± 0.00b 0.00 ± 0.00b 0.00 ± 0.00b 
Oleic acid 18:1n9c 18.10 ± 0.95 20.11 ± 1.96 18.95 ± 0.51 19.65 ± 0.25 
PUFAs     
Linoleic acid 18:2n6c 41.13 ± 2.12 48.79 ± 2.60 43.89 ± 0.51 47.43 ± 2.20  
α-linoleic acid C18:3n3 5.72 ± 0.24 7.03 ± 0.54 6.12 ± 0.17 6.77 ± 0.46 
Arachidonic acid C20:4 0.00 ± 0.00 0.00 ± 0.00 0.00 ± 0.00 0.00 ± 0.00 
Eicosapentaenoic acid C20:5n3 0.00 ± 0.00 0.00 ± 0.00 0.00 ± 0.00 0.00 ± 0.00  
Docosahexaenoic acid 22:6n3 0.00 ± 0.00 0.00 ± 0.00 0.00 ± 0.00 0.00 ± 0.00  
1 Values expressed as mean ± SEM (n = 3 samples/diet). Different superscript letters a, b,  
within the same row indicate significant difference at p < 0.05 by one-way ANOVA followed  
by Tukey’s test. Abbreviations: CSP, carp sarcoplasmic protein; MUFAs, monounsaturated fatty 
acids; PUFAs, polyunsaturated fatty acids; SFAs, saturated fatty acids.
  
104 
 
 
 
 
 
Figure 1: Body weights of female rats fed 10% protein diets consisting of carp sarcoplasmic 
protein (Carp), casein, whey protein isolate, or 2 weeks on 10% casein diet followed by a no-
protein diet. Values are mean ± SEM of n = 8 rats/group. Letters (a, b, c) shows significant 
difference at p < 0.05 determined by ANOVA followed by Tukey’s HSD.
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Table 4: Effect of the consumption of different diets substituted with 10% kcal protein consisting of carp  
sarcoplasmic protein, casein or whey protein for four weeks on growth parameters of growing female rats. 
 Treatment
1 
Growth Parameters CSP Casein Whey No-Protein 
Total diet intake (g) 449.98 ± 3.13a 441.65 ± 6.99a 460.49 ± 1.79a 380.59 ± 11.52b 
Caloric intake (kcal) 1664.91 ± 43.78a 1678.26 ± 26.57a 1749.87 ± 43.77a 1446.24 ± 43.78b 
Feed efficiency (g body wt/g diet intake) 0.16 ± 0.004b 0.19 ± 0.009ab 0.20 ± 0.006a 0.04 ± 0.007c 
Final body weight (g) 202.85 ± 3.33b 207.26 ± 2.89b 219.66 ± 2.66a 141.70 ± 2.98c 
Total body weight gain (g) 73.93 ± 1.71b 82.68 ± 4.04ab 93.69 ± 3.11a 15.82 ± 2.75c 
Liver weight (g) 8.45 ± 0.47a 8.48 ± 0.35a 9.54 ± 0.52a 5.4 ± 0.19b 
Relative liver weight (g / g bwt.) 4.15 ± 0.18 4.10 ± 0.14 4.18 ± 0.17 3.89 ± 0.15 
Gonadal fat pad weight (g) 2.62 ± 0.46b 3.26 ± 0.53ab 5.10 ± 0.68a 1.47 ± 0.35b 
Relative gonadal fat pad (g / g bwt) 1.28 ± 0.22b 1.57 ± 0.25ab 2.31 ± 0.31a 1.06 ± 0.25b 
1 Values expressed as mean ± SEM (n = 6–8 rats/group). Different superscript letters a, b, and c within the same row indicate 
significant difference at p < 0.05 by one-way ANOVA followed by Tukey’s HSD. Abbreviations: CSP, carp sarcoplasmic protein.
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Measurement CSP Casein Whey No-protein 
Steatosis Grade    
0 - 2 2 - 
1 3 1 1 - 
2 - - - 1 
3 - - - 2 
 
Figure 2: Representative histological staining images of the liver of growing female rats fed 
different proteins or no-protein diets. Arrows indicate locations of fat deposition. Scores 
analyzed by chi-square test at p <0.05.
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Table 5: Effect of the consumption of different diets substituted with 10% kcal protein of carp  
sarcoplasmic protein, casein or whey protein for four weeks on hepatic fatty acid composition 
and total lipid content. 
Measurements  
Treatments1  
CSP Casein Whey No-Protein  
SFAs (relative %)     
 
Palmitic acid 16:0 19.12 ± 1.57 19.53 ± 0.50 18.17 ± 1.58 19.66 ± 0.94  
Stearic acid 18:0 
19.88 ± 
1.29a 15.28 ± 1.71a 18.45 ± 0.79a 6.77 ± 0.43b 
 
MUFAs (relative %)     
 
Palmitoleic acid 16:1 1.03 ± 0.40 0.99 ± 0.27 0.95 ± 0.15 1.19 ± 0.08  
Oleic acid 18:1n9c 
10.18 ± 
1.99b 10.64 ± 1.96b 11.70 ± 0.94b 
20.81 ± 
1.29a 
 
PUFAs (relative %)     
 
Linoleic acid 18:2n6c 
11.74 ± 
1.31b 11.26 ± 2.07b 10.34 ± 0.62b 
23.21 ± 
1.67a 
 
α-linoleic acid C18:3n3 0.56 ± 0.06b 0.64 ± 0.10b 0.49 ± 0.04b 1.56 ± 0.09a  
 Arachidonic acid C20:4n6 0.00 ± 0.00 0.00 ± 0.00 0.00 ± 0.00 0.14 ± 0.03  
Eicosapentaenoic acid C20:5n3 0.00 ± 0.00 0.00 ± 0.00 0.00 ± 0.00 0.00 ± 0.00  
Docosahexaenoic acid 22:6n3 0.00 ± 0.00 0.00 ± 0.00 0.00 ± 0.00 0.00 ± 0.00  
Total Lipid Content (%) 6.91 ± 0.99b 8.73 ± 1.85b 4.62 ± 0.99b 
19.96 ± 
4.13a 
 
1 Values expressed as mean ± SEM (n = 6–8 rats/group). Different superscript letters a and b 
within the same row indicate significant difference at p < 0.05 by one-way ANOVA followed 
by Tukey’s test. Abbreviations: CSP, carp sarcoplasmic protein; MUFAs, monounsaturated 
fatty acids; PUFAs, polyunsaturated fatty acids; SFAs, saturated fatty acids. 
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Table 6: Effect of consumption of different diets substituted with 10% kcal protein of carp  
sarcoplasmic protein, casein or whey protein for four weeks by growing female rats on hepatic 
lipid metabolism gene expression. 
Measurements  
Treatments1 
CSP Casein Whey No-Protein 
Lipogenesis     
ChREBP 14.03 ± 3.91 19.5 ± 4.96 29.64 ± 5.99 19.22 ± 3.00 
SREBP1c 2.4 ± 0.57 1.54 ± 0.50 2.08 ± 0.51 1.69 ± 0.58 
SREBP2 3.79 ± 1.16 1.68 ± 0.82 2.68 ± 1.06 2.69 ± 0.76 
FAS 0.19 ± 0.06 0.17 ± 0.074 0.38 ± 0.11 0.22 ± 0.06 
SCD-1 2.16 ± 0.75 1.36 ± 0.40 2.05 ± 0.39 0.68 ± 0.33 
Lipolysis     
PPARα 0.79 ± 0.10 1.31 ± 0.35 1.46 ± 0.23 1.185 ± 0.24 
PPARγ 1.05 ± 0.28 0.9 ± 0.32 1.22 ± 0.36 0.55 ± 0.13 
HSL 0.2 ± 0.05 0.095 ± 0.02 0.13 ± 0.04 0.44 ± 0.16 
Storage and Transport     
DGAT2 1.92 ± 0.74 1.13 ± 0.21 3.14 ± 0.71 1.35 ± 0.69 
LPL 1.09 ± 0.28ab 1.24 ± 0.25a 0.78 ± 0.19ab 0.37 ± 0.09b 
MTTP 1.29 ± 0.48 1.18 ± 0.48 1.31 ± 0.42 1.59 ± 0.42 
Inflammation     
COX-2 1.1 ± 0.51 0.26 ± 0.19 0.074 ± 0.03 0.43 ± 0.28 
IL-10 0.43 ± 0.18 0.18 ± 0.07 0.17 ± 0.07 0.24 ± 0.12 
NFκB  1.06 ± 0.21 1.01 ± 0.17 1.25 ± 0.32 1.01 ± 0.28 
1 Values expressed as mean ± SEM (n = 6–8 rats/group) of transcript abundance (A) of gene of 
interest relative to housekeeping genes β-actin and GAPDH. Different superscript letters a and b 
within the same row indicate significant difference at p < 0.05 by one-way ANOVA followed by 
Tukey’s test. Abbreviations: CSP, carp sarcoplasmic protein; ChREBP, carbohydrate-response 
element-binding protein; SREBP-1c, Sterol regulatory element-binding protein-1c; SREBP-2, 
Sterol regulatory element-binding protein-2; FAS, fatty acid synthase; SCD-1, Stearoyl-CoA 
desaturase-1; PPARα, Peroxisome proliferator-activated receptor alpha; PPARγ, peroxisome 
proliferator-activated receptor gamma; HSL, hormone sensitive lipase; DGAT2, diacylglycerol 
O-acyltransferase 2; LPL, lipoprotein lipase; MTTP, microsomal triglyceride transfer protein; 
COX-2, cyclooxygenase 2; IL-10, interleukin 10; NFκB, nuclear factor kappa-light-chain-
enhancer of activated B cells;
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Table 7:  Effect of the consumption of different diets substituted with 10% kcal protein of carp  
sarcoplasmic protein, casein or whey for four weeks on gonadal adipose tissue fatty acid  
composition and total lipid content. 
Measurements  
Treatments1 
CSP Casein Whey No-Protein 
SFAs (relative %)     
Palmitic acid 16:0 24.54 ± 0.80 24.38 ± 0.82 24.45 ± 0.48 23.56 ± 1.03 
Stearic acid 18:0 3.91 ± 0.24 3.48 ± 0.11 3.90 ± 0.24 3.83 ± 0.22 
MUFAs (relative %)     
Palmitoleic acid 16:1 5.54 ± 0.30 5.84 ± 0.05 5.41 ± 0.27 5.29 ± 0.38 
Oleic acid 18:1n9c 29.29 ± 1.43 29.69 ± 1.32 30.81 ± 0.91 29.57 ± 1.30 
PUFAs (relative %)     
Linoleic acid 18:2n6c 20.72 ± 0.72 21.80 ± 0.57 22.59 ± 0.86 21.92 ± 0.62 
α-linoleic acid C18:3n3 2.17 ± 0.19 2.34 ± 0.12 2.31 ± 0.08 1.81 ± 0.12 
 Arachidonic acid C20:4 0.00 ± 0.00 0.00 ± 0.00 0.00 ± 0.00 0.00 ± 0.00 
Eicosapentaenoic acid C20:5n3 0.00 ± 0.00 0.00 ± 0.00 0.00 ± 0.00 0.00 ± 0.00 
Docosahexaenoic acid 22:6n3 0.00 ± 0.00 0.00 ± 0.00 0.00 ± 0.00 0.00 ± 0.00 
Total Lipid Content (%) 77.82 ± 5.56 73.66 ± 4.10 77.49 ± 2.62 66.57 ± 1.99 
1 Values expressed as mean ± SEM (n = 6–8 rats/group). Different superscript letters a, b, and c 
within the same row indicate significant difference at p < 0.05 by one-way ANOVA followed by 
Tukey’s test. Abbreviations: CSP, carp sarcoplasmic protein; MUFAs, monounsaturated fatty 
acids; PUFAs, polyunsaturated fatty acids; SFAs, saturated fatty acids. 
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Table 8: Effect of consumption of different diets substituted with 10% kcal protein of carp  
sarcoplasmic protein, casein or whey protein for four weeks by growing female rats on lipid 
metabolism gene expression in gonadal adipose tissue. 
Measurement 
Treatments1 
CSP Casein Whey No-Protein 
Lipogenesis     
ChREBP 1.33 ± 0.37 1.18 ± 0.29 1.22 ± 0.38 1.52 ± 0.40 
SREBP1c 1.22 ± 0.4 1.18 ± 0.32 2.02 ± 0.51 1.95 ± 0.51 
SREBP2 1.38 ± 0.37 1.03 ± 0.31 1.29 ± 0.22 1.43 ± 0.61 
FAS 2.18 ± 0.69 5.55 ± 1.69 5.3 ± 1.43 4.49 ± 1.91 
SCD-1 5.84 ± 2.18 3.42 ± 1.21 3.91 ± 1.42 1.59 ± 0.64 
Lipolysis     
PPARα 1.16 ± 0.36 1.50 ± 0.48 1.58 ± 0.54 2.72 ± 0.67 
PPARγ 2.61 ± 0.90 2.27 ± 0.77 3.41 ± 0.95 2.36 ± 0.71 
HSL 5.14 ± 1.97 3.84 ± 1.76 5.53 ± 1.73 6.62 ± 2.44 
Storage and Transport     
DGAT 0.25 ± 0.05 1.37 ± 0.47 1.88 ± 0.63 1.53 ± 0.48 
LPL 2.07 ± 0.74 2.21 ± 1.07 3.3 ± 1.13 1.81 ± 0.72 
MTTP 0.018 ± 0.018 0.74 ± 0.41 0.66 ± 0.17 0.34 ± 0.09 
Inflammation     
COX-2 0.0033 ± 0.001b 0.017 ± 0.0029a 0.0081 ± 0.0026ab 0.00051 ± 0.00025b 
IL-10 0.0013 ± 0.0003ab 0.0025 ± 0.0006a 0.0019 ± 0.0004ab 0.00065 ± 0.00025b 
NFκB  0.53 ±0.26 0.77 ± 0.38 0.58 ± 0.28 0.35 ± 0.09 
1 Values expressed as mean ± SEM (n = 6–8 rats/group) of transcript abundance (A) of gene of 
interest relative to housekeeping genes β-actin and GAPDH. Different superscript letters a and b 
within the same row indicate significant difference at p < 0.05 by one-way ANOVA followed by 
Tukey’s test. Abbreviations: CSP, carp sarcoplasmic protein; ChREBP, carbohydrate-response 
element-binding protein; SREBP-1c, Sterol regulatory element-binding protein-1c; SREBP-2, 
Sterol regulatory element-binding protein-2; FAS, fatty acid synthase; SCD-1, Stearoyl-CoA 
desaturase-1; PPARα, Peroxisome proliferator-activated receptor alpha; PPARγ, peroxisome 
proliferator-activated receptor gamma; HSL, hormone sensitive lipase; DGAT2, diacylglycerol 
O-acyltransferase 2; LPL, lipoprotein lipase; MTTP, microsomal triglyceride transfer protein; 
COX-2, cyclooxygenase 2; IL-10, interleukin 10; NFκB, nuclear factor kappa-light-chain-
enhancer of activated B cells; 
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Table 9: Effect of the consumption of different diets substituted with 10% kcal protein of carp  
sarcoplasmic protein, casein or whey protein for four weeks on serum measurements of liver  
function enzymes, cholesterol, and triglycerides. 
 Serum Measurements1 CSP Casein Whey No-Protein 
AST (U/L) 223.71 ± 34.01 195.83 ± 27.75 129.20 ± 20.27 163.33 ± 11.13 
ALT (U/L) 80.63 ± 14.21 67.71 ± 7.48 63.71 ± 10.22 64.57 ± 5.99 
VLDL-C/LDL-C (uM) 38.62 ± 7.37 38.83 ± 6.65 39.07 ± 8.07 19.54 ± 2.46 
HDL-C (uM) 14.02 ± 4.48 14.31 ± 3.94 20.05 ± 8.35 11.25 ± 3.77 
Total Cholesterol (uM) 52.64 ± 9.30 53.15 ± 5.97 59.12 ± 6.13 30.79 ± 4.49 
Triglycerides (mg/dl) 100.95 ± 9.95 98.09 ± 10.12 112.78 ± 8.77 95.31 ± 12.99 
1 Values expressed as mean ± SEM (n = 6–8 rats/group). Different superscript letters a, b, and c 
within the same row indicate significant difference at p < 0.05 by one-way ANOVA followed by 
Tukey’s test. Abbreviations: CSP, carp sarcoplasmic protein; AST, aspartate aminotransferase; 
ALT, alanine aminotransferase; VLDL-C, very low density lipoprotein cholesterol; LDL-C, low 
density lipoprotein cholesterol; HDL, high density lipoprotein. 
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Abstract 
Whey-based infant formulas have been reported to increase body weight gain and obesity risk. 
Protein content in infant formulas are often higher than human breastmilk resulting in elevated 
secretion of insulin like growth factor-1 (IGF-1) leading to anabolic metabolism. Previously, we 
determined water-soluble carp sarcoplasmic proteins (CSP) recovered in wash water to be a safe, 
with nutritional and functional values comparable to milk proteins, casein and whey protein. The 
objective of this study to investigate phenotypic and hepatic transcriptome responses due to low 
protein (10% kcal) diets consisting of CSP or milk proteins. Young (age 28 days) female 
Sprague-Dawley rats were randomly assigned (n=8 rats/group) to standard purified diet 
providing 10% CSP, casein, whey protein isolate or a protein-free diet. Following 4 weeks of 
feeding, liver total RNA was extracted from hepatic tissue samples. Total RNA samples of the 
highest quality (n = 4 rats/groups) underwent RNA sequencing. RNA sequencing reads were 
aligned, mapped, and assembled prior to differential gene expression. Transcripts per million for 
genes involved in branch chain amino acid (BCAA) metabolism, IGF-1 signaling pathway, and 
lipid metabolism were calculated for analysis. Whey protein isolate had the highest BCAA 
content compared to casein and CSP. This corresponded with greater (p < 0.05) final body 
weight and gonadal fat pad weight in whey protein compared to CSP and casein-fed rats. 
Consumption of the protein-free diet resulted in the greatest number (1,814) of differentially 
expressed genes compared to rats fed casein. Rats fed protein-free diet were separated from CSP, 
casein, and whey protein-fed rats which were arbitrarily clustered together. Among protein diets, 
abundance of IGF-1 transcripts were greater (p < 0.05) in rats consuming CSP and whey protein. 
However, there were no differences in gene transcript abundance in BCAA metabolism and the 
IGF-1 signaling cascade among diet groups. Collectively, results indicate diets with reduced 
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protein content (10% kcal) may not be sufficient to cause significant alterations to hepatic 
transcriptome. However, greater expression of IGF-1 can affect extrahepatic nutrient storage in 
adipose tissue.    
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1. Introduction 
 
According to the Food and Agriculture Organization of the United Nations (FAO), the global 
consumption of fish and other aquatic animals has quadrupled in the past 50 years. However, 
global fisheries are operating close to maximal levels with risk of depleting fish stock (FAO, 
2016). The FAO reported 3.3 percent reduction of aquaculture industries while the global human 
population is expected to exceed 10 billion by 2050 (FAO, 2016). To overcome limitations of 
natural resources, solutions need to be developed such as, utilization of less desirable fish 
species. Silver carp (Hypophthalmichthys molitrix) brought to the United States in the 1970s 
were unintentionally introduced to the Mississippi River due to flooding. Since their 
introduction, silver carp have become an invasive species (Chick 2001). Despite their abundance, 
silver carp are underutilized due to their boniness making consumption and processing difficult. 
However, silver carp could be processed into a nutritious, alternative protein source. 
All fish exceed the requirement of having more than 12 % energy from protein to be 
considered high in protein and are a good source of essential amino acids (Ruxton, 2011). 
Warren et al. (2018) investigated the recovery, drying, and in vitro characteristics of a protein-
rich silver carp sarcoplasm protein (CSP) powder. Results indicated no differences between the 
CSP and milk proteins, whey and casein. Whey and casein are used in protein supplements and 
infant formulas with long-term commercial success.  
Ong and others (2009) reported greater body weight gains in formula-fed infants compared to 
infants fed human milk due to increased insulin like growth factor 1 (IGF-1) and insulin 
excretion. IGF-1 is a protein synthesized and secreted by the liver with major regulatory roles in 
growth and metabolism by mediating the effects of growth hormone (GH). GH synthesis and 
secretion of IGF-1 is dependent on nutritional status and hormones such as insulin (Daughaday 
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and Rotwin, 1989). Diets low in protein have been shown to decrease plasma concentrations of 
IGF-1 in growing pigs (Deng et al., 2007). Dietary branch chain amino acids (BCAA) have been 
reported to induce IGF-1 excretion; however, the mechanism of action has not been well-studied. 
Wan et al. (2017) reported greater expression of IGF-1 from amino acid supplementation as a 
result of an interaction between mammalian target of rapamycin (mTOR), an important 
intracellular sensor for cell growth and autophagy, and peroxisome proliferator-activated 
receptor gamma (PPARγ), a transcription factors involved in the regulation of lipolysis. 
However, more mechanistic studies are needed. 
Compared to human milk, infant formulas often have higher protein content and is suggested 
to contribute to risk of obesity (Tang, 2018). Weight gain during the first year of life is one of the 
best indicators of later risk of obesity (Ong & Loos, 2006). This led to suggestions for infant 
formulas to lower amounts of protein and use high quality proteins to reduced risk of developing 
obesity later in life (Koletzko et al., 2009). Protein quality and physiological effects of proteins 
varies depending on its source. Song and others (2016) reported protein from beef, chicken, pork 
and carp sources in the recommended amount (18% by weight) for seven days resulted in distinct 
gene expression and physiological responses. Carp consumption was shown to downregulate 
genes regulating fatty acid oxidation and the synthesis of bile acids, triglycerides, and 
cholesterol. Therefore, the objective of this study was to investigate distinct phenotypic and 
hepatic transcriptome responses due to feeding low protein (10% kcal) diets consisting of CSP 
and milk proteins, casein and whey, in an animal model using growing rats.  
2. Materials and Methods 
2.1 Animals and Diets  
Immature (age 28 days) female Sprague-Dawley rats (n=32) were purchased from 
Charles River (Worcester, MA) and individually housed in metabolic cages for 4 weeks. 
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Following an acclimation period of 7-days, rats (n=32) were randomly assigned to four 
experimental groups (n = 8 rats/group) of purified standard rodent diet AIN-93G (American 
Institute of Nutrition-93Growth) consisting of different sources of protein: (1) AIN-93G with 
10% kcal CSP for 4 weeks, (2) AIN-93G with 10% kcal casein for 4 weeks, (3) AIN-93G with 
10% kcal whey protein for 4 weeks or, (4) AIN-93G with 10% kcal casein for 2 weeks followed 
by protein free diet for 2 weeks. Table 1 shows diet ingredients and composition. All 
experimental diets were isocaloric (3.7-3.8 kcal/g) with the only difference being protein source. 
All animal procedures were performed in accordance with National Research Council for the 
Care and Use of Laboratory Animals guidelines and approved by West Virginia University’s 
Animal Care and Use Committee (National Research Council, 2011).   
All diets as well as protein sources, casein and whey protein, were purchased from 
Envigo-Teklad (Madison, WI). Diets were stored at -20oC between feedings, Distilled deionized 
water (ddH2O) was provided ad libitum and replaced weekly. Rats were provided 20 g diet daily 
until normal diet consumption was established. Rats were then peer fed 16 ± 0.20 g diet/d.  
Following 4 weeks of feeding, rats were fasted overnight (12 h) and euthanized by carbon 
dioxide inhalation. The liver was removed, perfused, weighed, flash frozen in liquid nitrogen, 
and stored at -80oC for later analysis. 
2.2 RNA isolation and RNA Sequencing 
Total RNA was extracted from frozen hepatic tissue (50 mg) using the Zymo Research 
mRNA Isolation Kit (Irvine, CA, USA) according to the manufacturer’s instruction for total 
RNA isolation. Isolated RNA was treated with DNaseI with a TURBO DNA-free kit (Applied 
Biosystems, Foster City, CA, USA) and sent for quality assurance via bioanalyzer (Agilent, 
Santa Clara, CA). 
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RNA samples with the highest quality (RIN ≥ 6.8) from each experimental group (n=4) 
were selected for sequencing. Selected RNA samples were sent to Novogene Corporation (Chula 
Vista, CA, USA) for cDNA library construction (~300 bp) and RNA sequencing analysis 
(Illumina Platform PE150; Q30 ≥ 80%; 20M raw reads/sample). Briefly, data was imported into 
the Cyverse Discovery Environment (Cyverse, Tucson, AR, USA). RNA-Seq reads were aligned 
with RMTA v2.6.3 workflow by mapping reads to the Ensembl reference genome (vRnor_6) 
with HISAT2 then assembled using Stringtie and count reads using feature counts with default 
parameters.  
Differential gene expression was conducted using the DESeq2 package R Studio to read 
count tables. Similar to Song et al. (2016), experimental groups were compared to casein as a 
control to simplify the interpretation of the differential expression results. Results from DESeq2 
were imported into Ingenuity Pathway Analysis (Qiagen Inc, Germantown, MD, USA). The 
enrichment map generated using the Comparison Analysis plugin within the IPA software with 
the default settings with gene sets that passed conservative significant thresholds (p < 0.05, False 
Discovery Rate (FDR) < 0.10). A hierarchical cluster analysis heat map was produced using the 
feature counts with the R studio pheatmap package following log transformation. Transcripts per 
million for genes involved in the BCAA metabolism, IGF-1 signaling pathway, and lipid 
metabolism were calculated using Kallisto-0.42.3 application in the Cyverse discovery 
environment. Transcripts of interest were chain amino acid amino transferase (BCAA-AT), 
branch chain ketoacid hydrogenase (BCKA-DH), IGF-1, insulin like growth factor 1 receptor 
(IGF-1R), ras homolog enriched in brain (RHEB),  mTOR, sterol regulatory element-binding 
protein-2 (SREBP-2), and peroxisome proliferator-activated receptor gamma (PPARγ). 
2.2 Statistical analysis 
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A completely randomized design was used in the animal feeding study with n = 8 rats per 
experimental diet group. Results are expressed as mean ± standard error of the mean. One-way 
ANOVA was used to determine differences among diet treatment groups. Post-hoc multiple 
comparison tests were performed using Tukey’s test with treatment differences considered 
significant at p<0.05 and tendency at p=0.08. Statistical analyses were performed using JMP 
12.2 statistical software package (SAS Institute, Cary, NC). 
3. Results 
3.1 Dietary Amino Acid Profile and Growth 
Whey protein isolate had the greatest BCAA content at 262 mg/g protein compared to 
casein (222 mg/g protein) and CSP (148 mg/g protein) (Table 2). Leucine was the most 
abundant BCAA for the CSP, casein, and whey protein diets at 63 mg/g protein, 94 mg/g protein, 
and 143 mg/g protein, respectively.  
As shown in Figure 1, whey protein-fed rats had greater (p < 0.05) final body weight 
compared to rats fed CSP and casein. There were no body weight differences between casein and 
CSP-fed rats. Rats fed casein followed by a protein deficient diet for two weeks had the lowest (p 
< 0.05) final body weight. Rats were peer-fed therefore there were no differences in total diet 
intake or caloric intake among protein diet groups.  
Illustrated in Table 3, rats fed whey protein had greater (p < 0.05) gonadal fat pad weight 
compared to CSP and protein-free fed rats. Liver weights were greater (p < 0.05) in rats fed 10% 
protein as CSP, casein, and whey protein compared to the protein-free group. However, 
following body weight correction, weight difference was no longer statistically significant. 
3.2 RNA sequencing 
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RNA sequencing resulted in 21,629 transcripts expressed in rat hepatic tissue (Table 4). 
Whey protein-fed rats had more transcripts expressed (16, 994) compared to rats fed CSP, casein 
or protein-free diet. There were 6 differentially expressed transcripts when all diet groups were 
compared. Therefore, casein was used as a control to simplify the interpretation of the 
differential expression results. There were minimal differentially expressed transcripts when CSP 
and whey protein supplementation were compared to casein.  
Consumption of the protein-free diet for 2 weeks resulted in the greatest number (1,814) 
of differentially expressed genes when compared to casein-fed rats. The hierarchical cluster 
analysis of expressed transcripts is provided in Figure 2. Rats fed protein free diet were 
separated from rats fed CSP, casein, and whey protein which were arbitrarily clustered together. 
Subsequently, there were no differences in the comparison pathway analysis of differentially 
expressed genes among protein fed rats (Figure 3).  Rats fed protein free diet resulted in the 
enhancement of multiple pathways; however, PPAR and mTOR pathways were not enriched.  
3.3 IGF-1 Pathway 
Shown in Figure 5, there were no differences in transcript expression of genes involved 
in metabolism of BCAA (BCAA-AT, BCKA-DH). Abundance of IGF-1 transcripts were greater 
(p < 0.05) in rats consuming CSP and whey protein. However, there were no differences in 
transcript abundance of genes involved in IGF-1 signaling (IGF-1R, RHEB, mTOR,), 
lipogenesis (SREBP-2), and lipolysis (PPARγ). 
Discussion 
4.1 Dietary Amino Acid Profile and Growth 
In the current study, growing rats fed a protein deficient (0% kcals) diet for 2 weeks had 
the lowest body weight. Among protein diets, rats fed whey protein had significantly greater 
121 
 
final body weight compared to rats fed either CSP or casein. All experimental diets were 
isocaloric and adjusted for nutrients resulting in no differences in dietary lipid profile or content 
and therefore, the only difference was protein type. Comparing amino acid profiles of 
experimental diets showed whey protein diet had the greatest leucine and isoleucine content 
(Warren et al., 2018). BCAAs (leucine, isoleucine, and valine) have been reported to promote 
adipogenesis by stimulating insulin and IGF-1 (Melnik, 2012). In the current study, fat 
deposition depended on the protein source with greater gonadal adipose weight in growing rats 
consuming whey protein (Table 3). Others have suggested high whey protein consumption 
contributes to obesity and weight gain in infant (Tang, 2018; Koletzko et al., 2009). Investigating 
the effect of protein sources on fat deposition is important to further investigate since weight 
gain during early life has been reported to be one of the best indicators of later risk of obesity 
(Ong & Loos, 2006).  
The current study results suggest differences in phenotype were a result of the different 
protein sources. Leucine and isoleucine play an important role in the synthesis of proteins and 
other nitrogenous compounds, including transcription factors involved in lipid metabolism 
regulation (Nie et al., 2018). Therefore, RNA sequencing was used to identify the distinct hepatic 
transcriptome responses leading to the phenotype differences in growing rats fed low protein 
(10% kcal) diets provided as CSP or milk proteins, casein and whey. 
4.2 RNA Sequencing 
Minimal differences were identified among rat consuming different protein diet. The 
results suggest CSP, casein, and whey protein had comparable effects on the hepatic 
transcriptome. In contrast, Song et al., (2016) reported transcriptome alterations were not 
significantly different in rats fed 18% kcal protein diets sourced from beef, chicken, pork and 
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carp compared to casein as a control. Carp protein consumption had the greatest effects on gene 
sets describing fatty acid oxidation and the synthesis of bile acids, triglycerides, and cholesterol. 
No differences were reported in BCAAs and sulfur amino acids (cysteine and methionine) 
content amount the meat protein powders. Since lipid profiles were not assessed the observed 
alterations to lipid metabolism may have been a result of different dietary fatty acid. Our study 
indicates reduced protein (10% kcal) diets with similar fatty acid profiles (Supplemental Table 1) 
may not be sufficient to cause significant alterations to the hepatic transcriptome.  
In our study, rats provided a protein free diets for two weeks altered the hepatic 
transcription, as evident by the hierarchical cluster analysis and comparative pathway analysis. 
Particularly, isoleucine and valine degradation pathways were enriched in rats fed the protein 
free diet. Isoleucine and valine are branched chain as well as essential amino acids. Results 
suggest catabolism of BCAA may have been enhanced to compensate for the synthesis of other 
amino acids missing in the diet. Therefore, transcripts of genes involved in BCAA catabolism 
were assessed. 
4.2 Genes of Interest 
Catabolism of BCAA is important to maintain numerous homeostatic processes such as 
protein turnover and anabolism, fatty acid oxidation, and immune function (Knerr et al., 2012). 
BCAA metabolism occurs in the mitochondrial matrix with distinct pathways for each BCAA 
(McCalley et al., 2019). Following transport into the mitochondria, BCAAs undergo deamination 
via BCAA amino transferase (BCAA-AT) producing 2-oxo-branched chain organic acids. Once 
deamination occurs, BCAA alpha-keto acid dehydrogenase (BCAA-DH) produces branched-
chain acyl-coenzymes through oxidative decarboxylation. These enzymes are common in 
catabolism of all three BCAAs. Production of acetoacetate, acetyl-CoA, and propionyl-CoA via 
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specific acyl-CoA dehydrogenases is the final step in BCAA catabolism (Knerr et al., 2012). 
Products of BCAA catabolism can then entering the Kreb cycle for energy production. However, 
end products of leucine and isoleucine catabolism are substrates for fatty acid synthesis 
(Lehninger et al., 2013). Whey protein had higher leucine and isoleucine content which may 
have contributed to greater adiposity. However, no differences were identified in transcript 
abundance in BCAA-AT or BCAA-DH among experimental diets suggesting minimal 
differences in BCAA catabolism among diet groups.  
Previous research reported an increase secretion of IGF-1 potentiates greater body weight 
gains in infants fed whey-based formulas (Ong et al.,2009). PPARγ was reported to be crucial for 
gene expression of IGF-1 and is induced by amino acid concentration (Wan et al., 2017). PPARγ 
is one of a group of transcription factors that regulate metabolism cell, development, and 
differentiation (Ahmadian et al., 2013; Wright et al. 2014; Reynolds et al., 2015). Numerically, 
PPARγ expression was lowest in rats fed whey protein. Conversely, rats consuming whey 
protein and CSP diets resulted in greater (p < 0.05) IGF-1 transcript abundance compared to rats 
fed the protein free diet. Numerically, rats consuming whey protein had more IGF-1 transcripts. 
No differences were identified among diet groups when downstream molecules in the IGF-1 
pathway such as mTOR, an amino acid sensor for promoting growth and development, as well as 
SREBP-2, a regulator of de novo lipogenesis, were investigated (Jewell et al, 2013; Strable et al., 
2010). Results indicate IGF-1 expression, secretion and signaling pathway may have additional 
modulators in the liver.   
4. Conclusion 
In conclusion, results showed feeding a low protein (10% kcal) diet consisting of whey 
protein potentiates higher body weight and adipose deposition in growing rats. However, this 
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district phenotypic response was not imitated in the hepatic transcriptome indicated by negligible 
difference among protein-fed rats. Further, minimal differences in transcriptome abundance of 
gene modulating BCAA catabolism and the IGF-1 signaling pathway were identified among diet 
groups. However, IGF-1 transcript abundance was enhanced in CSP and whey protein-fed rats. 
Collectively, results indicate diets with reduced protein content (10% kcal) may not be 
sufficiently deficient to cause significant alterations to hepatic transcriptome. However, the 
greater expression of IGF-1 may affect nutrient storage in extrahepatic tissues such as adipose 
tissue.    
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6. Figures and Tables 
Table 1: Nutritional level and ingredient composition of experimental protein 
diets. 
 Items CSP Casein Whey No-Protein 
Selected Nutrient Information1    
Protein (%) 10 10 10.3 0 
Carbohydrate (%) 66.9 67.8 68.1 78.1 
Fat (%) 7 7.1 7 7 
Energy (kcal/g) 3.7 3.8 3.8 3.8 
Ingredient (g/kg) 1    
Whey Protein Isolate - - 111 - 
Casein - 115 - - 
Carp Protein  131.5 - - - 
Corn Starch 482.236 492.036 495.286 605.986 
Maltodextrin 132 132 132 132 
Sucrose 100 100 100 100 
Soybean Oil 66.5 70 70 70 
Cellulose 50 50 50 50 
Mineral Mix 13.4 13.4 13.4 13.4 
Calcium Phosphate 0.75 9.8 13.2 13.4 
Calcium Carbonate 11.1 5.25 2.6 2.7 
Vitamin Mix 10 10 10 10 
Choline Bitartate 2.5 2.5 2.5 2.5 
TBHQ 0.014 0.014 0.014 0.014 
Abbreviations: CSP, carp sarcoplasmic protein; TBHQ, Tertiary 
butylhydroquinone 
1 Received from Envigo-Teklad (Madison, WI) 
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Table 2: Amino analysis of carp sarcoplasmic protein, casein, and whey 
protein powders 
  CSP1  Casein2 Whey2 
Essential Amino Acid (mg/g protein)   
Valine 47.21 ± 0.18 70 56 
Leucine 62.96 ± 0.26 94 143 
Isoleucine 38.23 ± 0.14 58 63 
Threonine 32.13 ± 0.21 44 53 
Methionine + Cysteine 26.35 ± 0.27 31 64 
Phenylalanine + Tyrosine 64.74 ± 0.65 105 80 
Lysine 74.46 ± 0.44 82 112 
Histidine 43.62 ± 0.24 29 20 
Tryptophan 11.49 ± 0.16 12 24 
Arginine 37.72 ± 0.21 39 30 
Total Essential Amino Acid 438.91 506 563 
Non-essential amino acids (mg/g protein)   
Alanine 48.86 ± 0.22 32 57 
Glycine 51.07 ± 0.27 19 18 
Serine 28.17 ± 0.28 56 45 
Proline 23.31 ± 1.05 84 45 
Aspartic Acid 81.58 ± 0.42 71 125 
Glutamic Acid 83.74 ± 0.48 229 176 
Tyrosine 23.21 ± 0.18 54 42 
Cysteine 9.88 ± 0.03 4 40 
Taurine 25.98 ± 0.45 ND ND 
Total NEAA 375.8 549 548 
Abbreviations: CSP, carp sarcoplasmic protein; ND, no data 
Values are mean ± SEM with n = 3 samples/group. 
1 Based on Warren et al., 2018. 
2 Received from Envigo-Teklad (Madison, WI) 
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Figure 1: Body weights of female rats fed 10% protein diets consisting of carp sarcoplasmic 
protein (Carp), casein, whey protein isolate, or 2 weeks on 10% casein diet followed by a 
no-protein diet. Values are mean ± SEM of n = 8 rats/group. Letters (a, b, c) shows significant 
difference at p < 0.05 determined by ANOVA followed by Tukey’s HSD.
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Table 3: Effect of the consumption of different diets substituted with 10% kcal protein of carp sarcoplasmic protein, casein or 
whey for four weeks on growth parameters of growing female rats. 
 
 Treatment
1 
Growth Parameters CSP Casein Whey No-Protein 
Caloric intake (kcal) 1664.91 ± 43.78a 1678.26 ± 26.57a 1749.87 ± 43.77a 1446.24 ± 43.78b 
Final body weight (g) 202.85 ± 3.33b 207.26 ± 2.89b 219.66 ± 2.66a 141.70 ± 2.98c 
Total body weight gain (g) 73.93 ± 1.71b 82.68 ± 4.04ab 93.69 ± 3.11a 15.82 ± 2.75c 
Liver weight (g) 8.45 ± 0.47a 8.48 ± 0.35a 9.54 ± 0.52a 5.4 ± 0.19b 
Relative liver weight (g / g bwt.) 4.15 ± 0.18 4.10 ± 0.14 4.18 ± 0.17 3.89 ± 0.15 
Gonadal fat pad weight (g) 2.62 ± 0.46b 3.26 ± 0.53ab 5.10 ± 0.68a 1.47 ± 0.35b 
Relative gonadal fat pad (g / g bwt) 1.28 ± 0.22b 1.57 ± 0.25ab 2.31 ± 0.31a 1.06 ± 0.25b 
1 Values expressed as mean ± SEM (n = 6–8 rats/group). Different superscript letters a, b, and c within the same row indicate 
significant difference at p < 0.05 by one-way ANOVA followed by Tukey’s HSD. Abbreviations: CSP, carp sarcoplasmic protein. 
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Table 4: Statistics of transcript expression 
Class #1 %2 
Total Transcripts 32883 100 
Expressed Transcripts 21629 65.78 
Expressed in CSP 16692 77.17 
Expressed in Casein 16764 77.51 
Expressed in Whey 16994 78.57 
Expressed in No Protein 16947 78.35 
Differentially expressed transcripts (p<0.05; 
q<0.05)   
       Global 6 0.03 
       Carp to Casein 25 0.12 
       Whey to Casein  7 0.03 
       No Protein to Casein 1814 8.39 
1 # indicates the number of transcripts 
2 % indicates the percentage  
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Figure 2: Hierarchical cluster analysis of expressed genes in rats fed 10% kcal protein 
diets of carp sarcoplasmic protein (carp), casein, or whey and no protein (NP) diets for 
4 weeks. The level of expression was calculated by log transforming feature counts and 
compared among the diet groups (n=4). Highly expressed transcripts are red, lowly expressed 
transcripts are blue. 
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Figure 3: Comparison pathway analysis of differentially expressed genes in rats fed 
carp sarcoplasmic protein (carp), whey or no protein diets compared to rats fed casein 
as a control. Enriched pathways are red, suppressed pathways are blue. 
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Figure 4: Effect of the consumption of different diets substituted with 10% kcal protein of 
carp sarcoplasmic protein (carp), casein or whey for four weeks on hepatic transcript 
abundance of genes involved in branch chain amino acid metabolism. Values expressed as 
mean ± SEM (n = 4 rats/group). Abbreviations: BCAA-AT, branch chain amino acid 
aminotransferase; BCAA-DH, branch chain amino dehydrogenase. 
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Figure 5: Effect of the consumption of different diets substituted with 10% kcal protein of 
carp sarcoplasmic protein (carp), casein or whey for four weeks on hepatic transcript 
abundance of genes involved in the IGF-1 signaling pathway. Transcript abundance of 
insulin-like growth factor 1 (A), insulin like growth factor 1 receptor (B), and downstream 
regulatory molecules (C) were characterized. Values expressed as mean ± SEM (n = 4 
rats/group). Different letters a and b indicate significant difference at p < 0.05 by one-way 
ANOVA followed by Tukey’s test. Abbreviations: IGF1, insulin-like growth factor 1; IGF1R, 
insulin-like growth factor 1 receptor; Rheb, Ras homolog enriched in brain; mTOR, mammalian 
target of rapamycin; SREBP-2, sterol regulatory binding protein-2; PPARγ, peroxisome 
proliferator-activated receptor gamma. 
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7. Supplemental Table  
 
Table 5: Hepatic fatty acid composition and total lipid content after consuming diets 
substituted with 10% kcal protein of CSP, casein or whey protein for four weeks.  
Measurements  
Treatments1  
CSP Casein Whey No-Protein  
SFAs (relative %)     
 
Palmitic acid 16:0 19.12 ± 1.57 19.53 ± 0.50 18.17 ± 1.58 19.66 ± 0.94  
Stearic acid 18:0 
19.88 ± 
1.29a 15.28 ± 1.71a 18.45 ± 0.79a 6.77 ± 0.43b 
 
MUFAs (relative %)     
 
Palmitoleic acid 16:1 1.03 ± 0.40 0.99 ± 0.27 0.95 ± 0.15 1.19 ± 0.08  
Oleic acid 18:1n9c 
10.18 ± 
1.99b 10.64 ± 1.96b 11.70 ± 0.94b 
20.81 ± 
1.29a 
 
PUFAs (relative %)     
 
Linoleic acid 18:2n6c 
11.74 ± 
1.31b 11.26 ± 2.07b 10.34 ± 0.62b 
23.21 ± 
1.67a 
 
α-linoleic acid C18:3n3 0.56 ± 0.06b 0.64 ± 0.10b 0.49 ± 0.04b 1.56 ± 0.09a  
 Arachidonic acid C20:4n6 0.00 ± 0.00 0.00 ± 0.00 0.00 ± 0.00 0.14 ± 0.03  
Eicosapentaenoic acid C20:5n3 0.00 ± 0.00 0.00 ± 0.00 0.00 ± 0.00 0.00 ± 0.00  
Docosahexaenoic acid 22:6n3 0.00 ± 0.00 0.00 ± 0.00 0.00 ± 0.00 0.00 ± 0.00  
Total Lipid Content (%) 6.91 ± 0.99b 8.73 ± 1.85b 4.62 ± 0.99b 
19.96 ± 
4.13a 
 
1 Values expressed as mean ± SEM (n = 6–8 rats/group). Different superscript letters a and b 
within the same row indicate significant difference at p < 0.05 by one-way ANOVA followed by 
Tukey’s test. Abbreviations: CSP, carp sarcoplasmic protein; MUFAs, monounsaturated fatty 
acids; PUFAs, polyunsaturated fatty acids; SFAs, saturated fatty acids. 
  
138 
 
 
 
Chapter VI 
Summary and Future Directions 
Summary 
During processing of silver carp, water-soluble sarcoplasmic proteins lost in wash water, 
were recovered and freeze-dried into a protein-rich powder, CSP. For commercial and consumer 
acceptance, protein quality and safety of CSP must be evaluated by comparing CSP to popular 
commercially available proteins, casein and whey protein. Study 1 assessed the protein quality 
of CSP and effects of low (10% kcal) protein diets consisting of CSP, casein, and whey protein 
on growth, body composition, renal markers, and bone health. Results indicated protein quality 
of CSP was comparable to casein and whey protein. Further feeding low (10% kcal) protein diets 
supported rat growth within the normal range; however, whey protein-fed rats had greater 
gonadal adipose weight. Study 2 investigated low protein (10 % kcal) diets consisting of CSP, 
whey protein or casein effects on lipid metabolism in adipose tissue and liver compared to a 
protein-energy malnutrition diet. Results demonstrated CSP and casein and did not result in 
altered expression of genes regulating adiposity or liver lipid metabolism contributing to 
development of NAFLD. However, it has been suggested that whey protein consumption 
stimulates insulin and IGF-1 secretion, resulting in adipogenesis. Therefore, Study 3 assessed 
distinct hepatic transcriptome responses due to low protein (10% kcal) diets supplemented with 
CSP, casein, and whey protein compared to a protein-free diet. RNA sequencing of hepatic tissue 
revealed consumption of the protein-free diet resulted in the greatest number of differentially 
expressed genes compared to casein while CSP and whey protein consumption increased the 
abundance of IGF-1 transcripts. 
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Based on the results of the three studies, we concluded:  
1. Carp protein powder derived wash water provides a source of high-quality protein that 
may contribute to improved sustainability by reducing amount of protein consumed to 
support adequate body growth without affecting renal and bone health. 
2. CSP is a physiologically safe option but may be preferable to whey protein for 
preventing increased adiposity without detrimental effects on the liver and therefore, 
could be marketed as a sustainable alternative to current commercial protein powder. 
3. In low protein diets reduced protein content to 10% kcal did not cause significant 
alterations to hepatic transcriptome. However, greater hepatic expression of IGF-1 in 
whey-fed rats can affect nutrient storage in extrahepatic tissues. 
 
Future Direction 
Further studies are needed to investigate whether reduced protein diets sources from carp, 
casein, and whey alter nutrient storage in extrahepatic tissues by assessing transcriptome 
responses in adipose tissue. Additional CSP safety studies are needed to assess allergic response 
elicitation and potential heavy metal effects. Future pilot plant studies should investigate 
alternative recovery and drying methods to improve processing efficiency. Finally, product 
formulation testing should be done in order to bring the silver carp derived protein powder to 
market.  
 
 
 
 
 
